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This dissertation describes the total synthesis of the marine ladder toxin brevenal 
utilizing a convergent synthetic strategy. Critical to the success of this work was the use 
of olefinic-ester cyclization reactions and the utilization of glycal epoxides as precursors 
to C-C and C-H bonds. Previous total syntheses of brevenal and our strategy for the 
completion of the molecule are discussed in detail. 
In addition, olefinic-lactone cyclization reactions that result in the generation of 
macrocycles are described. The methodology was used to synthesize the natural 
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SO3 •py sulfur trioxide pyridine complex 
t triplet (spectral) 
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TBAI tetrabutylammonium iodide 
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THE TOTAL SYNTHESIS OF BREVENAL; SYNTHESIS OF THE  
 




  Introduction 
The term “red tide” refers to a phenomenon where harmful algae known as 
dinoflagellates accumulate rapidly along costal regions and results in the discoloration of 
surface water. The dinoflagellates have a dramatic effect on the life around them during 
the warm months of the summer when they “bloom” or reproduce.1 The species 
reproduce in such great numbers the water may appear red thus producing a “red tide”. 
These events are relatively common along the coast of Florida and are responsible for 
massive fish kills, neurotoxic shellfish poisoning and other human health problems.2 The 
potency of the red tide is governed by the concentrations of the marine dinoflagellates 
that produce a range of highly potent polycyclic ether toxins.1,2   
Among this array exist a structurally unique class of molecules called the 
brevetoxins that are produced by the dinoflagellate Karenia Brevis (Figure 1.1). Although 
unrelated to the red tide events, the ciguatoxins are a structurally similar class of 
molecules that are produced by the dinoflagellate Gambierdisicus Toxicus (Figure 1.2). 
The brevetoxins are associated with nuerotoxic shellfish poisoning (NSP) while the  
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ciguatoxins are associated with ciguatera poisoning.3-5 The environmental and human 
health effects associated with the two classes of molecules have attracted a great deal of 
attention from the scientific community. Unique to the blooms of Karenia Brevis is the 
associated aerosolized toxin component.6-8 Inhalation of the airborne brevetoxins causes 
respiratory distress to humans and other mammals along the shore of the red tide 
phenomena. Also, when humans consume shellfish contaminated with the brevetoxins 
mild to severe gastrointestinal and neurological symptoms may occur.9,5  
Much like the brevetoxins, the ciguatoxins display their poisoning effects through 
the same food chain cycle. Human consumption of infected marine animals causes 
“ciguatera poisoning” whose diagnosis relies on symptoms of muscle pain, diarrhea, 
vomiting and sensory disorders.3,4 These symptoms can last from weeks to years, and in 
extreme cases for as long as 20 years.10,11 
Despite the efforts the scientific community has put forth to understanding the 
biological properties of these molecules, there is no drug on the market to treat these 
illnesses. Perhaps the last place one may expect to find a drug candidate would be from 
the harmful algae blooms produced from K. Brevis. Yet, brevenal, a compound that has 
been shown to inhibit the binding of brevetoxins was found to be produced by K. Brevis. 
Brevenal represents one of the newest members of the brevetoxin family and was isolated 
from laboratory cultures of K. Brevis by Baden and coworkers.12-14 Brevenal’s structure 
closely resembles that of hemibrevetoxin B, isolated by Shimizu and coworkers in 1990, 
having a pentacyclic trans-fused polyether scaffold.15 Brevenal’s unique antagonistic 
properties were serendipitously discovered when A. Bourdelais prevented the death of 
guppies that were exposed to brevetoxin by treating them with a dilute sample of  
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brevenal.12,14 This result implies that brevenal acts as an antagonist towards brevetoxin. It 
has been shown that the brevetoxins and ciguatoxins exhibit their neurotoxicity by 
binding to the receptor site 5 of voltage-gated sodium channels (VGSC).16-19 VGSC’s are  
membrane proteins that allow sodium ions to pass through a cell's plasma membrane. The 
breveotoxins are thought to orient in a “head down” orientation into the VGSC as shown 
in Figure 1.3.20 When brevetoxins bind to the VGSC the channels open at normal resting 
potential with an increase in mean channel open time. This in turn causes a persistent 
depolarization of the cell and ultimately leads to apoptosis through inhibition of channel 
inactivation.21-23 
Lepage and co-workers were able to show that brevenal competitively displaces 
brevetoxin from site 5 on VGSC in rat brain synaptosome receptors in a concentration 
dependant manner with a Ki value of 1.85 µM.24 These results suggest that brevenal may 
be used to treat humans and marine organisms that have been exposed to brevetoxins.  
In another study, Abraham and co-workers studied the airway responses to 
inhaled brevetoxins and brevenal in a sheep asthma model that share many characteristics 
of the disease in humans. The inhalation of brevetoxins induce pathophysiologic effects 
such as bronchoconstriction and a decrease in tracheal mucous velocity.25  They were also 
able to show for the first time in vivo that brevenal is able to inhibit the brevetoxin-
induced bronchoconstriction. 
 Abraham found that brevenal provides the same increase in tracheal mucous 
velocity at one-million fold lower concentrations as seen with amiloride, a leading drug 
to improve mucociliary clearance in cystic fibrosis patients.25,26 Thus, brevenal, in 
addition to its potential thearupeutic abilities in the treatment of NSP,  shows promise for 
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the treatment of diseases associated with mucociliary dysfunction. 
 
Previous Syntheses 
A common feature of marine polycyclic ether natural products is a “ladder-shape” 
trans fused polyether skeleton composed of five to nine membered cyclic ether rings. The 
diverse molecular framework of polycyclic natural products that nature has produced has 
prompted equally diverse strategies to synthesize these molecules. Our group has 
developed a very flexible and iterative strategy to assemble the framework of polycyclic 
ether natural products, such as brevenal.27 However, before divulging our work, the 
previous synthesies of brevenal warrant discussion. From a chronological perspective, 
Sasaki’s synthesis of brevenal will be discussed first followed by work from Yamamoto 
and the Crimmins laboratories.  
 
    Sasaki’s synthesis 
 Sasaki and coworkers were the first to synthesize brevenal in 2006.28 Sasaki’s work 
led to a revision of the originally proposed structure of brevenal (Figure 1.4). On the 
basis of NMR distinctions between synthetic and natural brevenal, a revised structure 
differing only in the configuration of the C26 teriatary alcohol had been proposed and 
later confirmed by Sasaki’s total synthesis of brevenal.29 The revised structure 1.1 is also 
consistent with the biosynthetic pathway for polycyclic ether marine natural products 
proposed independently by Shimizu and Nakanishi.30-35 It is believed that nature 
constructs polycyclic ether natural products through a polyepoxide cyclization cascade as 
shown in Figure 1.5. From the poly-ene 1.3, a series of enzymatically-mediated 









              

































brevenal (proposed structure) 1.2
brevenal (revised structure) 1.1
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epoxidations occur to generate poly-epoxide 1.4.  Ring opening at the more substituted 
carbon with a molecule of water occurs with inversion of the epoxide stereochemistry 
thereby setting the C26 stereochemistry. 
Sasaki’s retrosynthetic plan is shown in Figure 1.6.29 Sasaki planned for the late 
stage introduction of both unsaturated side chains: The left hand side chain, containing a 
sensitive (E,E) diene moiety, was to be constructed using a Stille coupling between vinyl 
iodide 1.5 and vinyl stannane 1.6; and the right-hand-side chain was to be constructed 
from Wittig salt 1.7. The pentacyclic core was to be convergently synthesized through the 
coupling of AB ring enol phosphate 1.8 and the DE ring exocyclic enol ether 1.9 using a 
Suzuki-Miyaura coupling.         
The synthesis of the AB ring subunit commenced with Evan’s syn-aldol adduct 
1.10 prepared on gram scale (Figure 1.7) in order to meet the demands of material 
throughput.36 Treatment of the nitrile with DIBALH as the reducing agent gave the 
corresponding aldehyde. The aldehyde was then treated with a Wittig reagent to give the 
unsaturated ester 1.11 in 97% yield. Reduction of the ester with DIBALH gave the allylic 
alcohol. Sharpless asymmetric epoxidation of the resultant allylic alcohol 1.12 gave 
epoxide 1.13 as a single stereoisomer in 88% yield. The alcohol was oxidized to the 
aldehyde whereupon Wittig olefination provided the vinyl epoxide 1.14. In a single flask, 
Sasaki achieved oxidative cleavage of the PMB ether along with 6-endo ring closure 
forming the A ring 1.15.37 The free secondary alcohol was protected as  
a TES ether and hydroboration of the vinyl group with disiamylborane gave 1.16. 
Another oxidation/Wittig olefination reaction yielded the unsaturated ester 1.17. The 
cyclic lactone 1.18 was formed from 1.17 via TES ether cleavage, hydrogenation 
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1.11: R = CO2Me
R



































1.13: R = CH2OH
1.14: R = CH=CH2
1) iBu2AlH, CH2Cl2, 90%; 
2) Ph3P=C(Me)CO2Me,
    PhMe, 97%
iBu2AlH, 100%
 (+)-DET, Ti(Oi-Pr)4, t-BuOOH, 
CH2Cl2, -40 oC, 88%;
DDQ, CH2Cl2/ H2O
1) TESOTf, 2,6-lutidine, 
    CH2Cl2, 89% (two steps)
2) (Sia)2BH, THF; 
    NaOH (aq), H2O2, 92%
1) H2, Pd(OH)2/C,
    THF/MeOH,  90%;
2) 2,4,6-Cl3C6H2COCl, 
    Et3N, THF; DMAP, 98%
KHMDS, (PhO)2P(O)Cl, 
    HMPA,THF, 96%.
1) SO3‚pyridine,
    Et3N, 80%
2) Ph3PCHCO2Bn,
    PhMe, 86% 









1) SO3‚pyridine, Et3N, DMSO/CH2Cl2 
2) Ph3P+CH3Br-, NaHMDS 
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followed by lactonization using Yamaguchi’s protocol.38 Transformation of 1.8 to the 
requisite AB ring enol phosphate 1.18 was accomplished by treatment of 1.18 with the 
phosphorous oxychloride and base. 
 Sasaki’s stereoselective synthesis of the DE ring fragment (Figure 1.8) is 
reminiscent of Kadota and coworkers’ synthesis of the H ring of Gamberiol.39  They 
planned the construction of the seven-membered cyclic ether using an intramolecular 
reaction of an allylstannane with an aldehyde. They commenced the synthesis with 
benzylidene ester 1.19 that was prepared from 2-deoxy-D-ribose in three steps by a 
known procedure.40 The α,β−unsaturated ester was treated with ozone followed by a 
Wittig reaction to give olefin 1.20 in 80% yield. 
 Hydroboration of 1.20 with 9-BBN afforded the primary alcohol in 94% yield. 
Protecting group manipulations were then made to deprotect the secondary alcohol and 
selectively protect the primary alcohol as a TBS ether to give 1.21. The cyclization 
precursor 1.22 was then prepared through an allylation/stannylation procedure followed 
by oxidation to give the aldehyde 1.23. Sasaki was able to generate the oxepene 1.24 in 
excellent yield by treatment of 1.23 with BF3-OEt2.  
 With the D ring in hand, Sasaki set out to append the E ring using a samarium 
diiodide mediated reductive cyclization (Figure 1.9). Accessing the cyclization precursor 
required oxidation state and protecting group manipulation. Thus, benzylation then 
ozonolysis of 1.24 accompanied by a reductive workup afforded the alcohol which was 
protected as the benzyl ether to give 1.25. The acetal was then removed under acidic 
conditions giving diol 1.26 quantitatively.  A single flask triflation/TBS protection 
sequence was carried out yielding the primary triflate that was then directly subjected to  






























































O3, CH2Cl2; PPh3; 
Ph3P=CH3Br, NaHMDS, 80%
1)  9-BBN, THF; 
     3N NaOH, H2O2, 94%
2)TBAF, THF, 97%;
3) TBSCI, Et3N, DMAP, 96%
 1) allyl bromide, KH, 98%
2) sec-BuLi, TMEDA, THF;
    n-Bu3SnCl, 93%
1) TBAF, THF, 96%; 
2) SO3-py, DMSO,









































































 CSA, MeOH/CH2Cl2, 
    100% two steps
1) KOt-Bu, BnBr, n-Bu4NI, THF 
2) O3, CH2Cl2/MeOH; 
    NaBH4, 96% 2 steps
3) NaH, BnBr, THF/DMF
1) Tf2O, 2,6-lutidine, CH2Cl2; TBSOTf
2) allylMgBr, CuBr, Et2O, 85% 2 steps
1) OsO4, NMO, THF/H2O; NaIO4
2) HS(CH2)3SH, BF3‚OEt2, CH2Cl2
3) TBAF, THF, 88% 3 steps
1) methyl propiolate, 
    NMM, CH2Cl2;
2) MeI, NaHCO3, MeCN/H2O,
    99% 2 steps
1) iBu2AlH, CH2Cl2 
2) Ph3P+CH3Br-, NaHMDS, 
    THF, 94% (two steps)
3) TPAP, NMO, 4 Å MS, 
    CH2Cl2, 97%
SmI2, MeOH, THF;
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reaction with allyl cuprate giving the homologated product 1.27.41 Oxidative cleavage of 
the terminal olefin provided the aldehyde, which was protected as the dithiane. The silyl 
ether was cleaved and the resultant free alcohol 1.28 was subjected to hetero-Michael 
conditions using methyl propiolate as the Michael acceptor. The aldehyde was then 
unmasked to give the reductive cyclization precursor 1.29. Exposure of 1.29 to SmI2 
followed by acidic workup provided 1.30 as a single stereoisomer.42 Next, half reduction 
of the lactone using iBu2AlH at low temperatures was followed by Wittig reaction giving 
a terminal olefin. The secondary alcohol was oxidized to the ketone 1.31 using TPAP and 
NMO.43 
 Sasaki next targeted the C26 stereocenter.  Different methyl nucleophiles were 
investigated and it was found that addition of methyllithium in THF at -78 °C provided a 
10:1 mixture of diastereomers favoring the desired product 1.32 (Figure 1.10).  Sasaki 
confirmed the addition had provided the correct stereochemistry at C26 through an nOe 
correlations.29 The same NOE correlation was not observed for the undesired diasteromer.  
The tertiary alcohol 1.32 was protected as a TBS ether and the terminal olefin was 
then subjected to a hydroboration and oxidation sequence. The benzyl groups were 
reductively removed and the secondary alcohol was ultimately protected as the PMB 
ether 1.34 through a benzylidene acetal formation/iBu2AlH reduction sequence.  The 
exocyclic olefin was produced through an iodination and subsequent base promoted 
elimination to afford the DE ring coupling subunit 1.35. After Sasaki had finished the 
synthesis of both of the coupling subunits, he turned his attention to their coupling and 
the completion of brevenal’s pentacyclic core as shown in Figure 1.11. The coupling of 
the two subunits was achieved by using a Suzuki coupling reaction. 





       
 
 




















































1) TBSOTf, Et3N, 100% 
2) 9-BBN, THF, NaHCO3 (aq), H2O2
3) H2, 20% Pd(OH)2/C, MeOH 
4) p-MeOC6H4CH(OMe)2, PPTS, 
    CH2Cl2, 3 steps
1) KOt-Bu, BnBr, n-Bu4NI, THF
2) iBu2AlH, CH2Cl2, 87% 2 steps
1) I2, PPh3, imid., PhH
2) KOt-Bu, THF, 92% 2 steps
26
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1) BH3!SMe2, THF; 
    NaHCO3, H2O2, 
    81% 2 steps 
2) TPAP, NMO, 4 Å MS, 
    CH2Cl2, 98%
1) LiHMDS, TMSCl, Et3N 
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The requisite borane was generated from the DE ring exocyclic enol ether by treatment 
with 9-BBN. This was directly subjected to reaction with enol phosphate 1.8 under 
Suzuki conditions. The coupling product was isolated as a single stereoisomer. The 
ketone within 1.37 was installed through a hydroboration/oxidation sequence from enol 
ether 1.36. Oxidation of the enolate using OsO4 provided the α−hydroxyketone 1.38 in 
good yield.44 Reduction of 1.38 with iBu2AlH proceeded with good diasteroselectivity 
(10:1) to give the diol 1.39 (Figure 1.12). The diol 1.39 was bis-TES protected and the 
PMB ether was oxidatively cleaved providing a secondary alcohol, which was oxidized 
to the ketone 1.40 via TPAP and NMO conditions.43 To complete the core, the angular 
C19 methyl needed to be installed. This was done via formation of a mixed thioketal 
from the corresponding ketone 1.40. In a single flask, the thioketal was oxidized with 
mCPBA to the sulfone and then displaced with AlMe3 thereby setting the C19 angular 
methyl.45-47 The C14 alcohol was reprotected with TBSOTf to provide the pentacyclic 
polyether core of brevenal 1.41. In an additional eight steps intermediate 1.42 was 
obtained.  
 At this point, all that was left to complete the total synthesis of brevenal was: 1) 
introduction of the left (E,E)-dienal side chain; 2) introduction of the right-hand diene 
side chain; 3) global deprotection, and; 4) chemoselective oxidation. The installation of 
the (E,E)-dienal side chain was envisioned to utilize a Stille coupling. To do this, vinyl 
iodide 1.43 was regioselectivly synthesized from alkyne 1.42 through silylcupration using 
(Me2PhSi)2Cu(CN)Li2 followed by its treatment with NIS (Figure 1.13)48,49 Vinyl iodide 
1.43 was formed as a 9:1 mixture of regioisomers (Figure 1.13). After extensive model 
studies, optimal Stille coupling conditions were found when using Pd2(dba)3/Ph3As/CuTC  
	   20	  
 
                      
 









































































1) TESOTf, Et3N, CH2Cl2
2) DDQ, CH2Cl2/pH 7 buffer 
3) TPAP, NMO, 4 Å MS, 
     88% 3 steps
1) EtSH, Zn(OTf)2, CH2Cl2, 51%
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2) NIS, MeCN/THF 88% 2 steps




































1) TBDPSCl, imid., DMF, 87%
2) PPTS, CH2Cl2/MeOH, 70%
1) SO3-py, Et3N, CH2Cl2/DMSO 
2) n-BuLi, HMPA, THF, 1.47, 99% 2 steps
3) 30% H2O2, NaHCO3, THF, 78 %
1) TAS-F, THF/DMF 100%
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as the catalyst system  to provide 1.45 in 60% yield.50 The allylic alcohol was protected 
with TBDPSCl and the primary TES ether was cleaved with PPTS/MeOH to give 1.46. 
The right-hand (Z)-diene side chain was introduced using the procedure developed by 
Nicolaou et al. that consists of oxidation of the primary alcohol 1.46 to the aldehyde 
followed by Wittig olefination using ylide 1.47 and subsequent elimination of the 
selenide to give 1.48 in good yield.51,52 Finally, global deprotection and chemoselective 
oxidation of the C1 alcohol provided the dienal and completed the total synthesis of 
brevenal. Sasaki makes note that the synthetic brevenal exhibited identical spectral 
behavior to that of natural brevenal. The key features of Sasaki’s synthesis included a 
convergent assembly of the pentacyclic polyether skeleton by using a Suzuki-Miyaura 
cross coupling reaction. Also, the use of a CuTC promoted Stille reaction enabled Sasaki 
to stereoselectivity construct the left-hand (E,E)-diene system. Perhaps most importantly, 
Sasaki’s total synthesis proved the correct stereochemistry of the C26 tertiary alcohol.  
 
Kadota’s synthesis 
Kadota’s total synthesis of brevenal is unique to the three syntheses of brevenal 
that are to be discussed, in that, Kadota used an intramolecular allylation followed by 
subsequent ring-closing metathesis to form the pentacyclic core of brevenal.53 While 
certainly less convergent than Sasaki’s synthesis, having a longest linear sequence of 57 
steps, Kadota’s introduction of the side chains was comparatively concise. Figure 1.14 
illustrates Kadota’s retrosynthetic analysis of brevenal. The side chains would be 
introduced by Wittig and Horner-Wadsworth-Emmons olefinations. The pentacyclic 
ether core would be synthesized from 1.49 via intramolecular allylation followed 
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by ring-closing metathesis. The cyclization precursor 1.49 was retrosynthetically divided 
into the ABC ring subunit 1.51 and the E ring subunit 1.51. The tricycle 1.50 would be 
prepared from 1.52 and 1.53.  
Kadota’s synthesis of the ABC subunit commenced with known compound 1.54, 
which was prepared in four steps from 2-deoxy-D-ribose using Nicolau’s procedure 
(Figure 1.15).54 1.54 was subjected to multiple protecting group manipulations to give 
1.55. Ozonolysis of the terminal olefin present in 1.55 provided the requisite aldehyde for 
the Brown asymmetric allylation, which gave 1.56 as a single stereoisomer in high yield. 
The resultant alcohol was protected as a MOM ether and several oxidation state 
manipulations provided the carboxylic acid 1.57. Yamaguchi lactonization provided the 
B ring lactone, which was transformed to enol phosphate 1.58 in two additional 
steps.38,55,56  
The enol phosphate 1.58 underwent a Suzuki-Miyaura coupling with the alkyl 
borate 1.59 to give 1.60 (Figure 1.16).56 Hydroboration of 1.60 with BH3 followed by 
oxidative workup gave the undesired stereoisomer 1.61 as the sole product. Kadota set 
out to invert the C11 stereochemistry. This was carried out by oxidation of 1.61 to the 
ketone followed by epimerization with DBU to provide the correct C11 stereoisomer. 
Deprotection of the PMB ether using DDQ furnished alcohol 1.62 in 89% yield over 4 
steps. Next, the A ring was generated through a hydroxy-ketone cyclization to provide 
the corresponding mixed thioketal. The C12 angular methyl was installed analogously to  
Sasaki’s synthesis: namely, through the oxidation of the thioacetal with mCPBA followed 
by treatment with AlMe3 to give 1.63 as a single stereoisomer in good yield. 28,29,56 Seven 
additional steps were performed to give the ABC ring subunit 1.64. 
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95 % 2 steps
1) MOMCl, DIPEA, 95%




2) 2,4,6-trichlorobenzoyl chloride, 
    Et3N; DMAP, 67% 2 steps
3) KHMDS, (PhO)2POCl













          




















































3) DDQ, 89% 4 steps
1) EtSH, Zn(OTf)2, 89%
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The subunit coupling between the known carboxylic acid 1.64 and alcohol 1.51 
was performed using Yamaguchi conditions to provide the ester 1.65.57,38 (Figure 1.17) 
The intramolecular allylation precursor 1.67 was obtained in four additional steps. The 
allyl tin compound underwent intramolecular allylation upon treatment with MgBr2·OEt2 
to give 1.68 as a single stereoisomer. The pentacyclic core 1.69 was obtained through 
ring-closing metathesis of the diene 1.68 using Grubbs’ second-generation catalyst. 
Kadota next examined the construction of the right-hand (Z)-diene side chain. To do this, 
the TCBn moiety needed to be deprotected. This proved troublesome under standard 
hydrogenolysis conditions (H2/Pd-C). Kadota eventually found that the TcBn could be 
removed using Sajiki’s dechlorination procedure (H2/Pd-C, Et3N) to give the benzyl 
ether.58 Reduction of the E ring alkene with diimide followed by debenzylation and 
oxidation of the primary alcohol afforded 1.70, which is an intermediate in Sasaki’s 
synthesis.28,29 The spectral data of 1.70 matched  Sasaki’s and prompted the group to 
append the side chains and complete the synthesis.  
To append the right hand side chain, the primary alcohol in 1.70 was oxidized and 
the resulting aldehyde underwent reaction with the ylide 1.47.51,52 An oxidative work up 
provided the diene 1.71 as a single stereoisomer in good yield. (Figure 1.18).  Next, the 
installation of the A-ring side chain was attempted. Kadota’s method involved using a 
Horner-Wadsworth-Emmons reagent generated from 1.72 to stereoselectivity install the 
highly substituted (E,E)-diene moiety. Ester 1.73 was then reduced and the remaining 
silyl groups were removed. The allylic alcohol was then chemoselectivity oxidized using 
MnO2 to complete the synthesis of brevenal. Kadota makes note that the synthetic 
brevenal matched the spectral data of natural brevenal. 
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The key features of Kadota’s synthesis include an intramolecular allylation to form the 
pentacyclic polyether skeleton of brevenal and the stereoselective construction of the left-
hand multi-substituted (E,E)-diene system through an Horner-Wadsworth-Emmons 
reaction. Overall, the synthesis contained a longest linear sequence of 57 steps with an 
overall yield of 0.84%. Although Kadatoa’s synthesis is lengthier, his side chain 
installation is comparatively concise compared to Sasaki’s methods.  
 
Crimmins’ partial synthesis 
The most recent synthetic work that has been reported towards brevenal was 
Crimmins’ partial synthesis published in 2010. In brief, his work described the synthesis 
of an advanced intermediate using a convergent strategy. Although he has not completed 
the synthesis to date, his group has taken an interesting approach toward the molecule 
that warrants discussion.  
 Crimmins’ retrosynthetic analysis follows the usual protocol of installing the 
sensitive side chains late in the synthesis (Figure 1.19). He does not, however, go into the 
intricate details of their installation since his group has not reached that point in the 
synthesis. An acid catalyzed cyclization followed by dehydration of the enone-alchol 
system in 1.75 was proposed to form the D ring 1.74. The Horner-Wadsworth-Emmons 
union of the AB ketophosphonate 1.76 and the E ring containing aldehyde 1.77 was to 
give 1.75. Crimmins’ construction of AB ketophosphonate 1.76 and E ring aldehyde 1.77 
is centered on the ring-closing metathesis approach to medium sized rings.60,61  
 The synthesis commenced with a diastereoselective Evans’ aldol addition between 
phenylalanine derivative 1.78 and aldehyde 1.79 to give the 
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1,2-syn product 1.80 (Figure 1.20).62 The secondary alcohol of 1.80 was TMS protected 
and the auxiliary was cleaved under reductive conditions to give aldehyde 1.81.  A 
Horner-Wadsworth-Emmons coupling of β-ketophosphonate 1.82 with aldehyde 1.81 
provided the enone 1.83 in 90% yield as a single isomer.63 The α,β−unsaturation present 
in 1.83 was reduced using iBuAlH and MeCu and the TMS ether was removed to 
generate the A ring precursor 1.84.64 Subjection of 1.84 to cyclodehydration conditions 
provided enol ether 1.85 in excellent yield. Using Sasaki’s procedure, the angular methyl 
was installed through an epoxidation/thioketal formation and its oxidation to the 
corresponding sulfone.28 The sulfone was then displaced with retention of 
stereochemistry using AlMe3 to give 1.87. Reductive removal of the benzyl group and 
oxidation gave the corresponding aldehyde.65 Olefination of the aldehyde followed by 
TES deprotection gave 1.88. 
 With the requisite stereochemistry of the A-ring installed, the construction of the B 
ring was pursued (Figure 1.21). To do this, Crimmins used his glycolate alkylation/ring- 
closing metathesis strategy.60,61 This strategy nicely sets the B-ring stereochemistry and 
provides a handle for the introduction of the C13/C14 hydroxyl groups. To access 
glycolate alkylation precursor 1.91 the secondary alcohol 1.89 was alkylated with 
bromoacetic acid in the presence of sodium hydride.  The glycolic acid was converted to 
the mixed pivalic anhydride and treated with the lithiate of the valine derived auxiliary 
1.90 to give oxazolidinone 1.91. Diastereoselective alkylation of the sodium enolate of 
1.91 with bromoacetonitrile provided the nitrile in 58% yield. The chiral auxiliary was 
removed under reductive conditions to provide primary alcohol 1.92 which was oxidized 
to provide diene after Wittig olefination. Treatment of diene 1.93 with Grubbs’ second 
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Figure 1.20. Synthesis of the A-ring. 
 
1) iBu2AlH, HMPA
     cat. MeCu, 91%




























1) Na, napthalene, THF, 90%
2) Swern Oxidation, 91%
3) MePh3PBr, KOtBu, 96 %























    DMAP, CH2Cl2
2) DIBALH, CH2Cl2.






































  2) mCPBA, CH2Cl2;
   AlMe3, 78%












OH 1) NaH, BrCH2CO2H














1) NaHMDS, BrCH2CN, 58%



















1) Swern Oxidation, 95%












1) OsO4, NMO, 94%
2) 2-methoxypropene,















1) DIBALH, CH2Cl2, 80%

























	   35	  
generation catalyst provided the AB bicycle 1.94 in excellent yield.  By taking advantage 
of the olefin generated from the metathesis reaction, the C13/C14 diol was able to be 
installed through a highly diasteroselective dihydroxylation reaction. The diol was 
protected as the dimethyl acetonide 1.95 and its relative stereochemistry was confirmed 
by NOESY analysis. Next, the nitrile was reduced using iBuAlH to give the 
corresponding aldehyde, which was converted to the coupling precursor 1.76 in two 
additional steps. The AB-ring fragment was completed in 27 steps (longest linear 
sequence).  
 Efforts then focused on the synthesis of the E ring aldehyde 1.77 (Figure 1.22). An 
asymmetric aldol addition between oxazolidinone 1.96 and aldehyde 1.97 was used to set 
the C26 tertiary alcohol stereocenter providing 1.98 with superb diastereoselectivity (95:5 
dr).66 The auxiliary was converted to the methyl ester, and the free hydroxyl group was 
protected as a TES ether. The conversion of the methyl ester to aldehyde 1.99 was 
completed using a two-step reduction/oxidation sequence. After generation of the 
terminal olefin from the aldehyde functionality through a Wittig reaction, the TES group 
was removed to furnish alcohol 1.100. Crimmins used the analogous strategy that served 
to establish the B ring stereochemistry to create sterogenic centers in the E ring.60,61   
Alkylation of 1.100 with bromoacetic acid followed by coupling with oxazolidinone 
lithiate 1.90 provided glycoyl oxazolidinone 1.101 in 88% yield. Generation of the 
sodium enolate of 1.101 followed by alkylation with bromoacetonitrile produced the 
nitrile with excellent diastereoselectivity (95:5 dr). Reductive removal of the auxiliary 
then furnished the primary alcohol 1.102. The resultant hydroxyl group was oxidized to 
the aldehyde under Swern conditions and was then treated with divinyl zinc to give 
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a mixture of diastereomers 1.103.65 Exposure of this diastereomeric mixture to Grubbs’ 
second generation catalyst gave the epimeric cyclic ethers 1.104 and 1.105. The 
undesired diastereomer 1.104 could be converted to 1.105 via an oxidation/reduction 
sequence. Protection of 1.105 as a TES ether and reduction of the nitrile generated E-ring 
aldehyde 1.77.  
With both the AB ring β-ketophosphonate and E ring aldehyde prepared, attention 
was directed toward coupling of the fragments and completing brevenal. β- 
ketophosphonate 1.76 and aldehyde 1.77 were coupled using a Horner-Wadsworth-
Emmons reaction to provide the enone 1.75 in excellent yield (Figure 1.23) 
As this point in the synthesis, Crimmins’ envisioned that the formation of the D 
ring could be achieved through an acid-catalyzed cyclodehydration. Manipulation of the 
resulting enol ether 1.74 and formation of the C-ring could give the pentacyclic polyether 
core. Installation of the left- and right-hand side chains will then furnish brevenal 1.1.  
In summary, Crimmins’ reported a convergent and unique approach toward the 
total synthesis of brevenal. Utilizing the asymmetric glycolate alkylation/ring-closing 
metathesis method, both coupling fragments were synthesized. Crimmon’s efforts to 
complete the carbon framework and elaborate the side chains are ongoing in his 
laboratory. 
 
Results and Discussion 
 
The structural complexity and intriguing biological activities of marine polycyclic ether 
natural products prompted our group to initiate a program directed towards their 
synthesis. Through the development of an iterative synthetic strategy our research group 
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has synthesized a number of polycyclic ether natural products and analogues. 
Representative examples include the total synthesis of gambeierol,67 the formal synthesis 
of hemibrevetoxin B and its analogues,68,69 the A-E ring system of gambieric acid A, 70 the 
partial synthesis of adriatoxin,71 and the total synthesis of brevenal.72   
The basis of our strategy for the assembly of these molecules relies on three 
synthetic transformations as depicted in Figure 1.24: 1) the generation of a C-glycoside 
and/or C-ketoside 1.106, 1.107 through an oxidation/nucleophillic addition of an enol 
ether 1.108; 2) the synthesis of cyclic enol ethers 1.109 through olefinic-ester ring-
closing metathesis from the appropriate cyclization precursor 1.107, and; 3) the synthesis 
of cyclic enol ethers 1.110 using an acid catalyzed cyclization/elimination from substrates 
similar to 1.106.27 In the context of these reactions, the development of a synthesis that 
allows rapid access to the pentacyclic core structure of brevenal was proposed and the 
details of the approach are presented herein. 
Our synthetic strategy chosen for brevenal is depicted in Figure 1.25. As with all 
of previously published syntheses, we planned a late stage introduction of the sensitive 
diene and dienal side chains after the pentacyclic core of brevenal had been 
constructed.28,29,53 The generation of the D ring and completion of the core was envisioned 
to be possible through a reductive cyclization from the corresponding hydroxy ketone. 
The C ring was to be formed using our reduced titanium ethylidene reagent to effect the 
olefinic-ester cyclization of 1.113.73 At this point, we have chosen to retrosynthetically 
bifurcate 1.113 into the AB subunit 1.114 and the E ring subunit 1.115 thereby making 
the synthesis highly convergent. Their coupling was planned through an esterification 
reaction. The AB ring 1.114 was thought to be available through an acid mediated 










Figure 1.24. Our current strategy for the construction of polycyclic ether natural products.  
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cyclization/elimination sequence of 1.115 (Figure 1.26). The A ring enol ether would be 
generated from olefinic-ester substrate 1.116. The 1,2-syn stereochemistry present in 
1.116 would be established through a Brown crotylation reaction of aldehyde 1.117.74  As 
for the E ring, the olefinic-ester substrate 1.120 would provide the requisite oxepene ring 
that would then be oxidized and reduced to provide a handle for setting the C26 tertiary 
alcohol. The 1,2-trans-stereochemistry in 1.120 was to come from glyceraldeyhyde 
derivative 1.121.  
In this chapter, the stereoselective syntheses of the AB ring and the E ring 
fragments will first be presented.  A discussion of the union of the two fragments, 
synthesis of the pentacyclic core and completion of the molecule will then follow.  
 
Synthesis of the AB ring Fragment 
At the outset of this project, Dr. Henry Johnson established a synthetic route to 
the A ring through model studies.75 Although our strategy for the synthesis of the A ring 
was later modified for material throughput purposes, the model study was important for 
the completion of the molecule and warrants discussion. The synthesis of the A ring 
model system is shown in Figure 1.27. A Brown crotylation performed on aldehyde 1.122 
delivered the requisite 1,2-syn alcohol 1.123 in 90% yield and 86% ee.74 The absolute 
stereochemistry of 1.123 was established through Mosher ester analysis.76 The alcohol 
1.123 was subjected to esterification conditions using DCC/DMAP to obtain ester 1.124 
in 85% yield. A three-step one-carbon homologation involving: 1) hydroboration and 
oxidative work-up followed by; 2) oxidation to the aldehyde, and; 3) Wittig reaction 
provided the cyclization precursor 1.125. Subjection of the olefinic ester 1.125 to the  
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Takai-Utimoto reaction led to the formation of the corresponding acyclic enol 
ether. This was then treated with Grubbs’ second-generation catalyst to obtain cyclic enol 
ether 1.126 in 80% yield over two steps.  Oxidation of the enol ether with dimethyl 
dioxirane (DMDO) followed by immediate addition of AlMe3 led to the desired alcohol. 
Oxidation of the secondary alcohol to the ketone using TPAP and NMO occurred in 70% 
yield over two steps.43 The relative stereochemistry of 1.127 was confirmed by nOe 
analysis. 
The stereochemical outcome of the DMDO/AlMe3 reaction is rationalized in 
Figure 1.28. The epoxide 1.132 generated from the reaction of DMDO with glycal 1.128 
results from the epoxidation of the more abundant conformer 1.130. Although 1.130 and 
1.129 are in equilibrium, the bow-tie conformer 1.130 has the large -(CH2)4OTBDPS  
pseudoequatorial and will be present in greater concentration. The epoxidation of 1.128 is 
asynchronous and occurs from the α-face due to unfavorable steric interactions between 
the C12 pseudoaxial methyl with the approaching DMDO molecule. Next, syn addition of 
the methyl to the epoxide 1.132 occurs through complexation of AlMe3 to provide 1.133.  
Intramolecular methyl transfer to the oxonium ion then gives the product 1.134 after 
workup.76 
These initial model studies validated our strategy and encouraged us to carry out 
the synthesis of the AB ring diol 1.114 as per our retrosynthetic analysis shown in Figure 
1.26. Similar to our model studies, our synthesis of the AB diol 1.114 commenced with 
the crotyl adduct 1.123 (Figure 1.29). Esterification with the known carboxylic acid 1.135 
bearing the dimethylacetal moiety gave 1.136. The three-step one-carbon homologation 
sequence was employed to give olefinic ester 1.138. 







	  	  	  



























































	   47	  
The modest yield over the three reactions is attributed to the hydrolysis of the ester 
during the alkaline oxidative workup that follows the hydroboration to give diol 1.137. 
As demonstrated by Dr. Karthik Iyer, 1.137 could be recovered and transformed into the 
primary alcohol 1.138 in three steps that included: 1) chemoselective TES protection of 
the primary alcohol; 2) esterification of the secondary alcohol, and; 3) selective 
deprotection of the TES group (Figure 1.30).77 
Keeping in mind the need for this process to be amenable to scale, a more direct 
and simple approach was investigated that would bypass the formation of the diol 1.137. 
The obvious more efficient way to bypass the hydrolysis of the ester was to protect the 
secondary alcohol present in 1.123 with a group orthogonal to the TBDPS, such as a 
PMB group and delay the esterification until after the alkene has been homologated. 
Conditions to make the PMB ether were investigated and it was found that a concentrated 
reaction mixture and the use of KH as base gave the product 1.142 in excellent yield 
(Figure 1.31). 
Next, the three-step one-carbon homologation sequence was employed to provide 
1.143 in 73% yield over three steps; a significant improvement with respect to the 
process outlined in Figures 1.29 and 1.30. The success of these reactions allowed us to 
scale this sequence to a point where Brown crotylations were performed on a 90.0 gram 
scale allowing for significant quantities of 1.143 to be made. We next subjected the 
homologated product 1.143 to DDQ to oxidatively remove the PMB group to afford the 
secondary alcohol in 92% yield. Esterification of the secondary alcohol occurred 
quantitatively when an excess of the carboxylic acid 1.135 was used. 
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Our initial investigation of the conversion of olefinic ester 1.139 to cyclic enol ether 
1.145 employed the reduced titanium reagent derived from dibromomethane and resulted 
in the formation of a 1:1 mixture of cyclic enol ether 1.144 and acyclic enol ether 1.145 
in 70% yield.77 The acyclic enol ether could be transformed into cyclic material by 
subjection to Grubbs’ second generation catalyst.77   
During his work, Dr. Karthik Iyer found that a difference in the product 
distribution (acyclic vs. cyclic enol ether) could be controlled by using dibromoethane as 
the dibromoalkane source.73 The fact that cyclic material could be generated exclusively 
by utilizing a more substituted titanium alkylidene reagent was unprecedented. Our group 
has subsequently investigated the scope of the reaction and has found it to be broad.73 As 
part of this scope, we took olefinic-ester 1.139 and subjected it to the titanium ethylidene 
reagent. It was found that the reaction afforded the cyclic enol ether exclusively in 80% 
yield (Refer to chapter 2 for a more detailed discussion of olefinic-ester cyclizations). We 
next converted the enol ether 1.146 to the secondary alcohol 1.147 by utilizing our 
previously established method involving DMDO and AlMe3 to generate α-C-glycosides 
(Figure 1.32).76 Unfortunately, this strategy was unsuccessful and led to decomposition of 
the epoxide. To circumvent the problem, enol ether 1.146 was subjected to reaction with 
“acetone free” DMDO in CH2Cl2 at 0 0C to form the epoxide that was then directly 
subjected to AlMe3, without concentration, to provide the product as a single 
diastereomer in moderate yield. Although this modification of our protocol delivered the 
desired product 1.148, a significant amount of byproduct (35-55%) in which AlMe3 
addition occurred to the acetal was obtained.A number of conditions have been explored 
to avoid the formation of 1.147. 
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Figure 1.32. Epoxidation/AlMe3 addition and optimization of mixed acetal elimation.   
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Entry                                               Conditions                              Yield of 1.150
1 PPTS, Py, PhCl, 140 oC 24 %
2 BF3!OEt2, DIPEA, CH2Cl2  -78 oC to rt N.R.
3 Sc(OTf)3, Et3N, CH2Cl2,  -78 oC to rt dec.
5 TBSOTf, DIPEA, CH2Cl2  -78 oC to rt N.R.
4 TMSOTf, DIPEA, CH2Cl2  -78 oC to rt 90%
6 SnCl4, DIPEA, CH2Cl2  -78 oC to rt N.R.
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Different methyl nucleophiles and additives including sacrificial acetals and solvent 
screens were also carried out to no avail. The substrate was then modified to incorporate 
more hindered acetals in hopes of preventing AlMe3 coordination. Regardless of the 
nature of the acetal, the generation of the methyl adduct was still problematic. Different 
non-acetal groups such as silyl ethers and benzyl ethers were also investigated. These 
substrates delivered the product in low yields with various side products.  
Subjection of 1.148 to PPTS in chlorobenzene at 70 oC affected cyclization to 
give mixed cyclic acetal 1.149 in 91% yield. Next, mixed acetal 1.149 was subjected to 
PPTS, pyridine and heat to promote elimination to give the desired bicyclic enol ether in  
24% yield. In contrast to previous efforts, when we attempted the direct conversion from 
1.148 to 1.150, it led to decomposition. The low yields can be attributed to the mixed 
acetal’s instability to elevated temperatures. When the mixed acetal was subjected to the 
same conditions using lower temperatures, starting material was isolated. To overcome 
this problem, we investigated a variety of Lewis acid mediated elimination conditions 
and it was found that TMSOTf and excess of iPr2NEt lead to the formation of 1.150 in 
high yield. chloride at -78 0C ketone 1.152 was isolated exclusively. The resultant ketone 
is formed from a pinacol rearrangement that is speculated to be promoted by Lewis acidic 
magnesium salts from the Grignard reagent. After much experimentation, allyl addition 
was successful when the temperature of the Grignard addition was raised to 0 0C. The 
product 1.153 was obtained as a single diasterisomer in 82% yield. The ketone side 
product was still observed although to much lesser extent than when the addition was 
carried out at lower temperatures.Next, with oxepene 1.150 in hand, we investigated α-C- 
glycoside formation (Figure 1.33). 
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When 1.150 was initially subjected to DMDO and allyl magnesium chloride.  
To convert compound 1.153 to the desired coupling precursor 1.114, the C14 
hydroxyl group needed to be installed. To do this, the secondary alcohol present in 1.153 
was oxidized using TPAP/NMO in the presence of 4Å̊ molecular sieves to give the 
ketone 1.154 in 91% yield.43 The use of the Dess-Martin periodinane to oxidize 1.153 
gave comparable yields.78 
The ketone 1.154 was then subjected to a Rubottom oxidation sequence to give 
1.155 in 77% yield over two steps.79 Reduction of the ketone to form the desired 1,2-syn 
diol was attempted. However, iBuAlH reduction of the TES-protected hydroxyketone led 
exclusively to the undesired C14-C15 anti diol 1.156.77 
When the TES ether 1.155 was removed (CSA, MeOH:CH2Cl2, 90 %) and the 
resulting hydroxy ketone 1.157 was subjected to reductive conditions (iBuAlH, THF, -78 
0C) the reduction was found to give the C14-C15 syn diol 1.159 suggesting the 
importance of the free hydroxy group (Figure 1.34). This is similar to the results obtained 
by Sasaki as was shown in Figure 1.12.28 The stereochemical rationale for this result is as 
follows: Initially, the C14 hydroxy group is deprotonated with iBuAlH to form the 
corresponding aluminum alkoxide. Coordination to the adjacent C15 ketone gave the 
five-membered metallocycle 1.158, thereby blocking the β-side of the molecule and 
forcing the second equivalent of the reductant to approach from the less hindered α-side. 
The diol was obtained as a 10:1 mixture of diastereoisomers favoring the syn product. 
The two diastereoisomers could be separated by flash chromatography. The 
stereochemistry at the newly formed C14 and C15 positions were confirmed by nOe 
analysis of the acetonide 1.161 (Figure 1.35) 




Figure 1.34 Synthesis  of the C14-C15 syn diol 1.159. 	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To complete the synthesis of the coupling precursor, selective benzylation of the 
C14 hydroxyl group was achieved using the stannane complex derived from 
dibutyltinoxide and its subjection to CsF and benzyl bromide to provide exclusive 
formation of the C14 benzyl ether 1.114 in 72 % yield. Starting material could also be 
recovered in 23% yield. 
Our synthesis of the E ring acid commenced with (S)-2,3-O-isopropylidene 
glyceraldehyde 1.162 (Figure 1.36).80 In four steps, the olefinic ester 1.163 could be made 
in gram quantities. Subjection of 1.163 to the titanium ethylidene reagent affected 
cyclization to give the desired oxepene 1.164 in 72% yield. Oxidation of the enol ether 
with DMDO followed by iBuAlH reduction provided the secondary alcohol which was 
oxidized to the corresponding ketone 1.165 with TPAP/NMO in 80% overall yield. 
Methyl addition to the ketone using methyl magnesium bromide provided the C26 
tertiary alcohol 1.166 as a 6:1 mixture of diasterisomers favoring the desired compound. 
In an additional 5 steps, 1.166 was converted to the terminal olefin 1.167.  To make the 
carboxylic acid, the olefin 1.168 was dihydroxylated and the resultant diol was 
oxidatively cleaved to give an aldehyde. Pinnick oxidation provided the E ring coupling 
subunit 1.169.  
With the requisite fragments in hand, Dr. Jie Zhou set out to assemble the 
pentacyclic polyether core (Figure 1.37).81 Esterification of the coupling subunits was 
carried out using Yamaguchi’s protocol to afford the ester in 80% yield. The newly 
formed olefinic-ester 1.170 was subjected to the titanium ethylidene reagent to smoothly 
produce enol ether 1.171 in 72% yield. To complete the D ring the angular C19 methyl 
had to be installed. The first of several conditions used were a DMDO epoxidation  
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followed by AlMe3 addition. These conditions, however gave a 1:1.7 mixture of 
diastereoisomers 1.172 and 1.173 due to the lack of selectivity during the epoxidation 
step. Conditions developed by Dr. Jie Zhou that employ the use of DMDO/ ZnMe2 and  
TBSOTf were also explored. These conditions are known for generating axial addition 
products regardless of the epoxidation selectivity. When Dr. Zhou employed these 
conditions it was found that they gave irreproducible results that ultimately forced us to 
consider a different approach to synthesize the core.   
 
Second Generation Approach to Brevenal 
In order to circumvent the lack of selectivity from the previously described 
DMDO epoxidation/AlMe3 addition it was thought that the C19 methyl could be installed 
via a hydroxy ketone cyclization/methyl addition from the D ring enol ether 1.175 as 
shown in Figure 1.38. Here, we planned to use an olefinic ester cyclization from 1.176 to 
construct the D ring enol ether. Disconnection of the ester leads to the AB ring acid 1.177 
and E ring olefin 1.178.  
The AB ring coupling precursor 1.177 was formed in four steps from intermediate 
1.160, which involved bis-TES protection, dihydroxylation, oxidative cleavage and 
Pinnick oxidation (Figure 1.39). The E ring olefin 1.178 bearing the benzyl ether was 
made from the corresponding olefinic ester as previously described in Figure 1.36.  With 
both coupling partners in hand, fellow graduate student, Yuan Zhang began to investigate 
their coupling.  
The esterification of E ring acid 1.178 and AB alcohol 1.177 using Yamaguchi’s 
protocol produced moderate yields and we were unable to recover starting material  
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Figure (1.40).38 We then turned to Shiina’s protocol to affect ester formation and were 
delighted to isolate ester 1.181 in 87% yield under these conditions.82  
Next, olefinic ester cyclization using our titanium ethylidene reagent provided the 
D ring enol ether 1.182 with concomitant formation of acyclic enol ether 1.183 (Figure 
1.41). The acyclic material 1.183 could be transformed into cyclic enol ether 1.182 by 
treatment with Grubbs’ second generation catalyst. The next step was the installation of 
the ketone that was necessary for the formation of the C ring. This was accomplished by 
using a DMDO epoxidation/iBu2AlH reduction sequence to give the secondary alcohol as 
a single stereoisomer. The secondary alcohol was oxidized with TPAP/NMO to give the 
ketone 1.184 in 65% from 1.182.43 During the formation of the thioacetal from 1.184 the 
C14 and C15 TES ethers were removed which induced cyclization to give a mixed thiol 
ketal. The free C14 hydroxyl group was protected as the TBS ether 1.185. Installation of 
the angular methyl and construction of the pentacyclic core of brevenal occurred 
uneventfully when 1.185 was treated with ZnMe2 and Zn(OTf)2. The spectral data for 
structure 1.186, a synthetic intermediate in both Sasaki’s and Kadota’s syntheses, 
matched their reported 1H and 13C NMR data.28,53 Our total synthesis of brevenal was 
completed using a modification of Yamamoto and Kadota’s end game protocol for the 
incorporation of the side chains.28,53 The 1H and 13C NMR spectra of our synthetic 1.1 
were in accordance with those of the naturally obtained material.  
The key features of our synthesis include a convergent assembly of the 
pentacyclic polyether skeleton through an esterification reaction and the use of our 
olefinic ester metathesis strategy to generate the A, D and E rings of brevenal. Through 
the collaboration with Tom Murray, the material generated will serve to aid the	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understanding of brevenal’s biological properties. This study demonstrates the important 
role of total synthesis in the study of complex, biologically active natural products. 
Moreover, the highly convergent nature of the present synthesis will allow the synthesis 
of structural analogues for a more detailed structure-activity relationship studies of this 
intriguing natural product. 
 
Supporting Information 
General Experimental Procedures 
  Unless otherwise noted, all reactions were performed under a nitrogen atmosphere 
in flame-dried glassware. NMR spectra were recorded on a Varian VXR-500 MHz 
spectrometer. Chemical shifts were reported in δ, parts per million (ppm), relative to 
benzene (7.16), dichloromethane (5.32) or chloroform (7.27) as internal standards. 
Coupling constants, J, were reported in Hertz (Hz) and refer to apparent peak 
multiplicities. IR spectra were recorded on a Bruker Tensor 27 FT-IR spectrometer. Mass 
spectra were recorded at the Mass Spectrometry Facility at the Department of Chemistry 
of the University of Utah at Salt Lake City on a Finnigan MAT 95 mass spectrometer. 
Dichloromethane, TMEDA and pyridine were dried by distillation from calcium hydride 
and saturated with nitrogen. Tetrahydrofuran and diethyl ether were dried from the 
sodium ketyl of benzophenone and distilled before use. Zinc dust (<10 μm, Aldrich) was 
activated by washing with 5% hydrochloric acid, H2O, ether, and acetone and dried in 
vacuo overnight. The activated zinc was stored under nitrogen in a dessicator. All other 
reagents were used without further purification unless otherwise noted. Analytical thin–
layer chromatography (TLC) was performed on silica gel plates (0.25 mm) precoated 
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with a fluorescent indicator. Flash chromatography was performed using 40–63 μm silica 
gel (200 X 400 mesh).  
 
(3S,4S)-7-(tert-butyldiphenylsilyloxy)-3-methylhept-1-en-4-ol 1.123. A flame dried 3-
neck 3.0 L flask equipped with an internal thermometer was charged with potassium tert-
butoxide (33.80 g, 301.3 mmol and THF (205.0 mL). The slurry was cooled to -78 oC and 
cis-2-butene (56.00 mL, 625 mmol) was added followed by the dropwise addition of n-
butyllithium (120.5 mL of a 2.5 M soln. in THF, 301 mmol). During the addition of n-
butyllithium the temperature was maintained below -70 oC. After complete addition of n-
butyllithium, the mixture was stirred at -45 oC for 12 min. The resulting solution was 
recooled to -78 oC, and to it was added dropwise (+)-β-methoxydiisopinocamphenyl 
borane (361 ml of a 1 M solution in Et2O, 361 mmol) and the temperature was 
maintained below -70 oC. The reaction mixture was stirred at -78 oC for 30 min and boron 
trifluoride etherate (50.9 mL, 400 mmol) was added dropwise. Then neat aldehyde 1.122 
(82.0 g, 251 mmol) was added dropwise at -78 OC. The reaction mixture was stirred at -
78 oC for 3 h at which point aq. NaOH (376 ml of a 3.0 M aq. solution, 1004 mmol) 
followed by aq. H2O2 (160 ml of a 30 % solution). The reaction mixture was warmed to rt 
for 1 h and then diluted with hexanes (500 ml). The organic phase was washed with H2O 
(2 X 30 ml), dried (Na2SO4) and concentrated. The resulting residue was distilled (145 
oC, 0.01 torr) to remove pineol. Flash chromatography of the resulting residue 
(hexanes/EtOAc 100:1 to 10:1) yielded alcohol 1.123 (86.1 g, 90%, 95:5 er) as a 
colorless oil whose spectroscopic details were in accordance with that previously 
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reported77: Rf  0.35 (5:1 hexanes/EtOAc); 1H NMR (500 MHz, C6D6) δ 7.81-7.76 (m, 4 
H), 7.27-7.22 (m, 6 H), 5.70 (ddd, J = 17.1, 10.7, 7.8 Hz, 1 H), 5.01-4.95 (m, 2 H), 3.7-
3.62 (m, 2 H), 3.34-3.26 (m, 1 H), 2.10 (dddd, J = 13.7, 6.8, 6.8, 6.8 Hz, 1 H), 1.77-1.68 
(m, 1 H), 1.62-150 (m, 2 H), 1.38-1.28 (m, 1 H), 1.18 (s, 9 H), 1.00 (d, J = 6.8 Hz, 3 H); 
13C NMR (125 MHz, C6D6) δ 142.2, 136.4, 134.6, 130.3, 128.4, 115.0, 74.9, 64.9, 44.7, 
31.8, 29.9, 27.5, 19.8, 15.3. 
 
t-butyl-(4S,5S)-4-4-methoxybenzyl-5-methylhept-6-en-1-yl diphenylsilane 1.142. To a 
solution of alcohol 1.123 (60.1 g, 158 mmol) in THF (250 ml) at rt was added KH (26.2 
g, 196 mmol) as a 30% dispersion in mineral oil. The reaction mixture was allowed to stir 
for 20 min. at which point the color of the reaction mixture appeared yellow. PMB-Br 
(39.0 g, 196 mmol) was added over 20 min. After 12 h the reaction was quenched with 
sat. NH4Cl (aq., 100 mL). The aqueous phase was extracted with CH2Cl2 (3 × 100 mL), 
dried (Na2SO4), and concentrated. Flash chromatography (hexanes:ethyl acetates, 50:1 to 
20:1 to 10:1) gave 1.142 (69.1 g, 90%)  Rf 0.40 (20:1 hexanes/EtOAc); [α]D20 = +14.7° (c 
= 1.6, CH2Cl2); 1H NMR (500 MHz, C6D6) δ 7.79 (m, 4H), 7.25 (m, 8H), 6.82 (d, J = 8.3 
Hz, 2H) 5.88 (ddd, J = 17.4, 10.4, 7.2 Hz, 1H), 5.03 (m, 2H), 4.36 (s, 2H), 3.69 (m, 2H), 
3.32 (s, 3H), 3.17 (m, 1H), 2.44 (m, 1H), 1.83-1.50 (m, 4H), 1.94 (s, 9H), 1.07 (d, J = 
6.84 Hz, 1H). 13C NMR (125 MHz, C6D6) δ 160.0, 142.0, 136.4, 134.9, 132.1, 130.4, 
129.7, 128.7, 128.5, 114.6, 114.5, 82.8, 71.8, 64.9, 55.2, 41.6, 29.3, 28.0. 27.6, 19.8, 
16.3; DEPT (125 MHz, C6D6) δ CH3: 55.2, 27.6, 16.3, CH2 114.6, 71.8, 64.9, 29.3, 28.0 
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1248, 1084 cm-1; ESI/MS (m/z) calcd for C32H42O3SiNa 525.28 (M+Na+), found 525.3.  
 
t-butyl(((4S,5S)-4-((4-methoxybenzyl)oxy)-5-methyloct-7-en-1-yl)oxy) diphenylsilane 
1.143. To a solution of alkene 1.142 (38.0 g, 77.75 mmol) in THF (1.5 L) at -10 oC was 
added BH3-DMS (62.0 ml, 10.0 M in THF). The reaction mixture was stirred at this 
temperature for 5 h and then warmed to rt and stirred for an additional 2 h. The reaction 
mixture was recooled to 0 oC at which point aq. NaOH (300 mL 3.0 M) was slowly added 
followed by H2O2 (aq. 30%, 101 mL). The reaction mixture was allowed to stir at rt for 
12 h. The aqueous phase was extracted with CH2Cl2 (3 × 100 mL). The extracts were 
combined, dried (Na2SO4), and concentrated. The resulting residue was passed through a 
plug of silica (hexanes:ethyl acetates, 1:1) to give the corresponding primary alcohol 
which was carried on to the oxidation step without additional purification. Rf 0.30 (1:1 
hexanes/EtOAc); Crude spectroscopic data: 1H NMR (500 MHz, C6D6) δ 7.79 (m, 4H), 
7.24-7.22 (m, 8H), 6.80 (d, J = 8.8 Hz, 1H), 4.33 (ABq, J = 11.24 Hz, 2H), 4.22 (bs, 1H), 
3.72-3.65 (m, 2H), 3.56 (ddd, J = 10.9, 5.5, 5.4 Hz, 1H), 3.46 (m, 2H), 3.31 (s, 3H), 3.16 
(m, 1H), 1.89 (m, 1H), 1.83-1.52 (m, 7H), 1.94 (s, 9H), 0.85 (d, J = 6.84 Hz, 3H); 13C 
NMR (125 MHz, C6D6) δ 160.0, 136.4, 130.3, 129.9, 114.4, 83.3, 71.7, 64.7, 61.7, 55.1, 
36.2, 34.9, 30.1, 27.8, 27.5, 27.1, 26.8, 16.6. IR (film) 3416, 2919, 2848, 1632, 1427 cm-
1; ESI/MS (m/z) calcd for C32H44O4SiNa 543.29 (M+Na+), found 543.3.  
 To a solution of the crude primary alcohol from above (20.0 g, 38.4 mmol) in 
CH2Cl2 (350 ml) was added Dess-Martin periodinane (18.0 g, 42.24 mmol) at rt. The 
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M) and sat. NaHCO3  (aq., 100 mL) was added and allowed to stir for 30 min. The 
reaction mixture was diluted with Et2O (100 ml). The organic phase was separated, dried 
(Na2SO4) and concentrated to afford the crude aldehyde, which was carried on to the 
Wittig reaction without additional purification.  
 The crude aldehyde (42.24 mmol) from above was diluted in THF (350 ml) and the 
Wittig reagent (73 mmol, prep. according to the procedure below) was then added slowly. 
After 2 h the reaction was quenched with sat. NH4Cl (aq., 100 ml) and extracted with 
CH2Cl2 (3 X 50 ml). The extracts were combined, dried (Na2SO4) and concentrated. 
Flash chromatography (hexane/EtOAc 20:1) yielded alkene 1.143 (29.3 g, 73 % over 
three steps) as a colorless oil. The Wittig reagent was prepared as follows: to 
methyltriphenyl phosphonium bromide (27.4 g, 76.8 mmol) in THF (200 ml) at rt was 
added a solution of potassium tert-butoxide (73.0 ml of a 1 M soln. in THF) dropwise. 
The resulting yellow solution was used as described above after stirring for 1 h. Rf  0.75 
(10:1 hexanes/EtOAc); [α]D20 = +7.6 (c = 1.9, CH2Cl2);   1H NMR (500 MHz, C6D6) δ 
7.80 (m, 4H), 7.24 (m, 6H), 6.81 (d, J = 8.8 Hz, 2H), 5.77 (dddd, J = 17.1, 10.2, 7.0, 7.0 
Hz, 1H), 5.07-5.02 (m, 2H), 4.36 (ABq, J = 11.72 Hz, 2H), 3.70 (m, 2H), 3.31 (s, 3H), 
3.21 (dt, J = 8.8, 4.9 Hz, 1H), 2.36 (ddd, J = 13.4, 6.6, 5.1 Hz, 1H), 1.94 (m, 1H), 1.76-
1.55 (m, 5H), 1.20 (s, 9H), 0.96 (d, J = 6.8 Hz, 3H); 13C NMR (125 MHz, C6D6) δ 173.7, 
160.0, 138.6, 136.4, 134.8, 134.8, 132.3, 130.3, 129.7, 128.7, 128.4, 116.2, 114.4, 82.4, 
71.8, 64.8, 55.1, 38.0, 36.4, 29.8, 27.5, 27.4, 19.8, 15.2; DEPT (125 MHz, C6D6) δ CH3: 
55.1, 27.5, 15.2 CH2: 71.8, 64.8, 38.0, 29.8, 27.4 CH: 138.6, 136.4, 130.3, 129.7, 128.7, 
128.4, 1162, 114.4; ESI/MS (m/z) calcd for C33H44O3SiNa (M+Na+) 539.30, found 539.3.  
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(4S,5S)-1-((tert-butyldiphenylsilyl)oxy)-5-methyloct-7-en-4-ol 1.144. To a solution of 
PMB ether 1.144 (21.0 g, 40.7 mmol) in CH2Cl2 (300 mL) and aq. pH 7 buffer solution 
(30 mL, 1.0 M) at rt was added DDQ (13.85 g, 61.0 mmol) in a single portion. The 
reaction mixture was allowed to stir for 1.5 h and was then quenched by addition of 
saturated aq. NaHCO3 solution (50 mL). The phases were separated and the aqueous 
phase was extracted three times with CH2Cl2 (100 mL). The combined organic phases 
were dried (Na2SO4), filtered, and concentrated. Flash chromatography (hexanes:ethyl 
acetates, 20:1 to 10:1 to 5:1) gave 1.144 (14.85 g, 92%)  Rf 0.20 (10:1 hexanes/EtOAc); 
[α]D20 = -3.30 ° (c = 1.55, THF); 1H NMR (500 MHz, C6D6) δ 7.79-7.45 (m, 4 H), 7.25-
7.21 (m, 6 H), 5.74 (dddd, J = 17.5, 10.8, 8.0 Hz, 1 H), 5.06-4.90 (m, 2 H), 3.64 (t, J = 
5.8 Hz, 2 H), 3.40-3.33 (m, 1 H), 2.20 (ddd, J = 12.0, 6.0, Hz, 1 H), 1.89 (ddd, J = 14.8, 
8.0 Hz, 1 H), 1.71-1.62 (m, 1 H), 1.57-1.49 (m, 1 H), 1.44-1.34 (m, 2 H), 1.17 (s, 9 H), 
0.87 (d, J = 6.5 Hz, 3 H); 13C NMR (125 MHz, C6D6) δ 138.4, 136.4, 136.4, 134.6, 130.4, 
128.4, 116.2, 74.3, 64.9, 39.1, 38.8, 31.9, 30.1, 27.4, 19.8, 14.0 DEPT (125 MHz, C6D6) δ 
CH3: 27.4, 13.9 CH2: 116.2, 64.9, 38.8, 31.9 CH: 138.4, 136.4, 136.4, 130.4, 128.4, 74.3, 
39.1; IR (film) 3432, 2956, 2861, 1108 ESI/MS (m/z) calcd for C25H36O2SiNa (M+Na+) 
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anoate 1.136. To the alcohol (7.7 g, 21.6 mmol) in CH2Cl2 (100.0 ml) at rt was added the 
acid 1.123 (4.2 g in 10.0 ml CH2Cl2, 25.9 mmol), followed by 1,3 
dicyclohexylcarbodiimide (13.33 g, 64.7 mmol), then DMAP (5.20 g, 43.1 mmol). The 
reaction mixture was stirred at rt for 12 h and then concentrated. Flash chromatography 
(100:1 hexane:EtOAc, then 20:1 hexane:EtOAc) gave 11.08 g (95% yield) of 1.136 as a 
colorless oil whose spectroscopic details were in accordance with that previously 
reported77: Rf 0.51 (5:1 hexanes/EtOAc); 1H NMR (500 MHz, C6D6) δ 7.82-7.77 (m, 4 
H), 7.28-7.22 (m, 6 H), 5.71 (dddd, J = 17.1, 9.8, 7.3, 7.3 Hz, 1 H), 5.08 (ddd, J = 7.8, 
3.9, 3.9 Hz, 1 H), 5.05 (d, J = 1.4 Hz, 0.5 H), 5.02 (bs, 1 H), 5.0 (bs, 0.5 H), 4.25 (t, J = 
5.3 Hz, 1 H), 3.71-3.61 (m, 2 H), 3.11 (s, 6 H), 2.17 (t, J = 7.3 Hz, 2 H), 1.82 (ddd, J = 
15.6, 8.3, 8.3 Hz, 1 H), 1.76-1.68 (m, 2 H), 1.67-1.52 (m, 8 H), 1.18 (s, 9 H), 0.89 (d, J = 
6.8 Hz, 3 H); 13C NMR (125 MHz, C6D6) δ 173.0, 137.5, 136.4, 134.5, 130.3, 128.4, 




propoxy)diphenylsilane 1.145. An oven dried two-necked flask fitted with a condenser 
was cooled to 0 °C and charged with CH2Cl2 (1320 ml) followed by TiCl4 (32.0 ml, 56.0 
mmol). To the resulting solution was added THF (155.6 ml, 1774 mmol) dropwise at 
which time the solution turned yellow. The addition of THF was followed by the 
dropwise addition of TMEDA (267.7 ml, 1774 mmol) resulting in the formation of a 
brown solution. The ice bath was removed and the mixture was allowed to stir for 20 
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min. Activated Zn dust (43.2 g, 665 mmol) and PbCl2 (9.76 g, 35.1 mmol) were then 
added. The resulting mixture went through a series of color changes from brown to green 
to purple and finally to blue-green over the course of 3-5 min. To the slurry was 
transferred a solution of ester 1.139 (10.0 g, 18.5 mmol) and CH3CHBr2 (26 ml, 295 
mmol) in CH2Cl2 (127.0 ml + 127.0 ml rinse) via cannula. The reaction mixture was then 
heated to reflux for 2 h. Following this time period the mixture was cooled to 0 °C and 
quenched with sat K2CO3 (aq., 162 ml). After stirring for 30 min at 0 °C, the resulting 
mixture was filtered washing with 1:1 EtOAc (3 x 200 mL) and the filtrate was 
concentrated.  The resulting residue was taken up in 100:1 hexanes:EtOAc and filtered 
through a plug of silica (100:1 hexanes:EtOAc) to give a yellow oil. Flash 
chromatography (100:1 hexane:EtOAc, then 20:1 hexane:EtOAc) gave 7.73 g (82% 
yield) of cyclic enol ether 1.145 as a colorless oil whose spectroscopic details were in 
accordance with that previously reported 77: Rf 0.43 (10:1 hexanes/EtOAc); 1H NMR 
(500 MHz, C6D6) δ 7.81-7.78 (m, 4 H), 7.22-7.26 (m, 6 H), 4.42 (dd, J = 3.9, 2.9 Hz, 1 
H), 4.36-4.33 (m, 1 H), 3.75-3.65 (m, 3 H), 3.150 (s, 3 H), 3.148 (s, 3 H), 2.16-2.06 (m, 3 
H), 1.87-1.80 (m, 2 H), 1.73-1.53 (m, 5 H), 1.42-1.35 (m, 3 H), 1.19 (s, 9 H), 0.86 (d, J = 
6.8 Hz, 3 H); 13C NMR (125 MHz, C6D6) δ 153.3, 136.0, 134.4, 129.9, 128.3, 104.5, 
93.7, 77.9, 64.2, 52.11, 52.08, 34.3, 32.3, 29.63, 29.60, 29.1 27.8, 27.1, 22.7, 19.5, 13.5. 
 
(2R,3S,5S,6S)-6-(3-(tert-butyldiphenylsilyloxy)propyl)-2-(4,4-dimethoxybutyl)-2,5-
dimethyltetrahydro-2H-pyran-3-ol 1.148. To 1.146 (675 mg, 1.32 mmol) in CH2Cl2 
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CH2Cl2, 1.65 mmol) dropwise. The reaction mixture was warmed to 0 oC over 25 min 
after which it was recooled to -78 oC, and AlMe3 (3.30 ml of a 2 M solution in hexane, 
6.6 mmol) was added dropwise. The reaction mixture was stirred at this temperature for 
8-10 min then warmed to 0 oC over 2-3 min at which time it was quenched with sat. pH 
7.0 phosphate buffer (aq., 10.0 ml), extracted with CH2Cl2 (4 X 30 ml), dried with 
Na2SO4 and concentrated. Flash chromatography (3:1 hexane:EtOAc to 1:1 
hexane:EtOAc) gave .351 g (49 % yield) of 1.148 as a colorless oil whose spectroscopic 
details were in accordance with that previously reported77: Rf 0.67 (1:1 hexanes/EtOAc); 
1H NMR (500 MHz, C6D6) δ 7.83-7.77 (m, 4 H), 7.27-7.22 (m, 6 H), 4.36 (t, J = 4.9 Hz, 
1 H), 3.75-3.63 (m, 2 H), 3.50 (m, 1 H), 3.33 (ddd, J = 8.3, 4.4, 2.4 Hz, 1 H), 3.16 (s, 6 
H), 1.82-1.43 (m, 11 H), 1.40 (ddd, J = 12.2, 4.9, 2.4 Hz, 1 H), 1.33-1.25 (m, 1 H), 1.19 
(s, 9 H), 1.05 (s, 3 H), 0.87 (d, J = 6.8 Hz, 3 H); 13C NMR (125 MHz, C6D6) δ 136.4, 
134.9, 130.3, 128.7, 105.2, 77.2, 71.6, 68.5, 64.7, 52.60, 52.59, 41.50, 37.0, 34.0, 33.7, 
30.3, 29.9, 27.5, 19.9, 18.6, 15.4, 13.0. 
 
(2R,3S,5S,6S)-6-(3-((tert-butyl-diphenylsilyl)oxy)propyl)-2-(4-methoxy-pentyl)-2,5-
dimethyl-tetrahydro-2H-pyran-3-ol 1.147. Alcohol 1.147 was obtained as an undesired 
product when the procedure to synthesize 1.148 was carried out. Rf 0.70 (1:1 
hexanes/EtOAc); [α]D20 = -7.2° (c = 0.9, CH2Cl2); 1H NMR (500 MHz, C6D6) δ; 7.80 (dd, 
J = 7.8, 4.4 Hz, 4H), 7.24 (m, 6H), 3.74-6.64 (m, 3H), 3.52 (dd, J = 11.7, 4.9 Hz, 1H), 
3.35 (dddd, J =8.7, 4.3, 2.1, 2.1 Hz, 1H), 3.15 (s, 3H), 1.81-1.26 (m, 15H), 1.14 (s, 9H), 
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MHz, C6D6) δ 136.4, 130.3, 128.7, 128.4, 77.3, 77.3, 71.5, 68.6, 68.5, 64.7, 56.1, 56.1, 
41.8, 38.0, 37.0, 33.7, 30.3, 30.0, 27.5, 19.7, 19.6, 19.4, 19.3, 15.5, 15.4, 13.0; DEPT 
(125 MHz, C6D6) δ CH3: 27.5, 19.6, 19.6, 15.5, 15.5, 13.0 CH2 41.8, 38.0, 37.0, 30.3, 
30.0, 19.4, 19.3 CH: 136.4, 130.3, 128.7, 128.4, 77.3, 77.3, 71.5, 68.6, 68.5, 33.7; IR 
(film) 3400, 2917, 2849, 1540, 1456, 1109 cm-1; ESI/MS (m/z) calcd for C32H50O4SiNa 
549.3 (M+Na+), found 549.3; for C32H50O4SiK 565.3 (M+K+), found 565.3. 
 
tert-butyl-(3-((2S,3S,4aS,9aR)-6-methoxy-3,9a-dimethyloctahydro-2H-pyrano [3,2b]-
oxepin-2-yl)propoxy)diphenylsilane 1.149. To a solution of 1.148 (0.91 g, 1.67 mmol) 
in benzene (60 ml) at rt was added PPTS (0.75 g, 0.1 mmol). The reaction was heated at 
reflux for 1 h at which point it was cooled to rt and concentrated. Flash chromatography 
of the resulting residue (hexanes:EtOAc 20:1) gave 0.77 g (91 % yield) of mixed cyclic 
acetal (dr = 10:1 α:β) 1.149 as a colorless oil whose spectroscopic details were in 
accordance with that previously reported77: Rf 0.40 (10:1 hexanes/EtOAc); 1H NMR (500 
MHz, C6D6) δ 7.83-7.77 (m, 4 H), 7.26-7.22 (m, 6 H), 4.42 (dd, J = 8.8, 5.9 Hz, 1 H), 
3.99 (dd, J = 12.2, 4.9 Hz, 1 H), 3.77-3.65 (m, 2 H), 3.49-3.44 (m, 1 H), 3.26 (s, 3 H), 
1.88-1.22 (m, 13 H), 1.20 (s, 3 H), 1.19 (s, 9 H), 0.95 (d, J = 6.84 Hz, 3 H); 13C NMR 
(125 MHz, C6D6) δ 136.4, 134.8, 130.3, 128.7, 103.1, 76.7, 71.2, 67.0, 64.7, 55.2, 45.7, 
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b]oxepin-2-yl)propoxy)diphenylsilane 1.150. To 1.149 (1.04 g, 2.04 mmol) in CH2Cl2 
(10.0 ml) at -78o C was added DIPEA (3.56 mL, 20.48 mmol) followed by TMSOTf 
(1.74 ml of a 1 M solution in Et2O, 3.48 mmol). The reaction mixture was warmed to 0 
oC over 1 h at which point the reaction mixture was concentrated. Flash chromatography 
using neutralized silica (hexanes:EtOAc 50:1) gave 0.887 g (90 % yield) of 1.150 as a 
colorless oil whose spectroscopic details were in accordance with that previously 
reported 77: Rf 0.71 (10:1 hexanes/EtOAc); 1H NMR (500 MHz, C6D6) δ 7.82-7.77 (m, 4 
H), 7.25-7.22 (m, 6 H), 6.35 (dd, J = 7.3, 2.4 Hz, 1 H), 4.53 (ddd, J = 7.3, 7.3, 2.9 Hz, 1 
H), 3.75-3.64 (m, 2 H), 3.61 (dd, J = 11.7, 4.9 Hz, 1 H), 3.4 (ddd, J = 8.3, 4.4, 2.5 Hz, 1 
H), 1.99-1.71 (m, 5 H), 1.63-1.25 (m, 6 H), 1.19 (s, 9 H), 1.09 (s, 3 H), 0.86 (d, J = 6.8 
Hz, 3 H); 13C NMR (125 MHz, C6D6) δ 147.5, 136.4, 134.9, 130.3, 128.7, 108.2, 80.7, 
78.1, 71.3, 64.7, 42.1, 35.4, 33.3, 30.2, 29.7, 27.5, 22.0, 19.9, 13.7, 12.8. 
 
(2S,3S,4aS,6R,7S,9aR)-6-allyl-2-(3-(t-butyl-diphenyl-silyloxy)-propyl)-3,9a-di-methyl 
octahydro-2H-pyrano[3,2-b]oxepin-7-ol 1.153. To the enol ether 1.151 (0.210 g, 0.439 
mmol) in CH2Cl2  (60 ml) at -78 oC was added “acetone free” DMDO (2.41 ml of a 0.2 M 
soln. in CH2Cl2, 0.483 mmol) dropwise. The reaction mixture was warmed to 0 oC while 
stirring over 30 min at which point allyl magnesium chloride (4.40 ml of a 2 M soln. in 
THF, 8.78 mmol) was added at once. The mixture was warmed to rt over 30 min, 
quenched with sat. NH4Cl (aq., 20 ml), extracted with CH2Cl2 (3 X 50 ml), dried 
(Na2SO4), and then concentrated. Flash chromatography (hexane:EtOAc 5:1 to 3:1) gave 
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accordance with that previously reported 77: Rf 0.55 (3:1 hexanes/EtOAc); 1H NMR (500 
MHz, C6D6) δ 7.83-7.8 (m, 4 H), 7.26-7.22 (m, 6 H), 5.95-5.85 (m, 1 H), 5.06-4.99 (m, 2 
H), 3.80-3.66 (m, 3 H), 3.55 (ddd, J = 6.4, 6.4, 2.4 Hz, 1 H), 3.51-3.45 (m, 2 H), 2.23-
2.06 (m, 3 H), 1.84-1.28 (m, 10 H), 1.20 (s, 3 H), 1.19 (s, 9 H), 0.95 (d, J = 7.3 Hz, 1 H); 
13C NMR (125 MHz, C6D6) δ 136.4, 136.1, 134.9, 130.2, 117.8, 85.2, 77.1, 75.4, 74.1, 
71.4, 64.8, 40.1, 36.2, 35.4, 33.5, 30.6, 30.3, 29.9, 27.5, 19.9, 16.3, 13.1. 
 
(2S,3S,4aS,6R,9aR)-6-allyl-2-(3-(tert-butyl-diphenylsilyl-oxy)propyl)-3,9a-dimethyl 
hexahydro-2H-pyrano[3,2-b]oxepin-7(3H)-one 1.154. To the alcohol 1.153 (0.252 g, 
0.47 mmol) in CH2Cl2 (20 ml) at rt was added 4Å MS (0.300 g), NMO (0.275 g, 2.35 
mmol) and TPAP (ca 10 mg). The reaction was stirred at this temperature for 3 h at 
which point the reaction was loaded directly onto silica gel. Flash chromatography 
(hexane:EtOAc 20:1 to 10:1) gave 0.233 g (93 % yield) of ketone 1.154 as a colorless oil 
whose spectroscopic details were in accordance with that previously reported: Rf 0.35 
(3:1 hexanes/EtOAc); 1H NMR (500 MHz, C6D6) δ 7.82-7.76 (m, 4 H), 7.26-7.22 (m, 6 
H), 5.85 (dddd, J = 17.1, 10.3, 7.3, 7.3 Hz, 1 H), 5.03 (m, 0.5 H), 5.01 (m, 0.5 H), 4.99 
(m, 1 H), 3.78 (dd, J = 6.8, 5.4 Hz, 1 H), 3.73-3.62 (m, 2 H), 3.39 (ddd, J = 7.3, 4.4, 2.4 
Hz, 1 H), 3.07 (dd, J = 12.2., 4.9 Hz, 1 H), 2.52 (ddd, J = 12.7, 12.7, 5.4 Hz, 1 H), 2.37-
2.25 (m, 2 H), 2.20-2.14 (m, 1 H), 1.75-1.40 (m, 8 H), 1.29-1.21(m, 1 H), 1.19 (s, 9 H), 
1.13 (s, 3 H), 0.76 (d, J = 6.8 Hz, 3 H); 13C NMR (125 MHz, C6D6) δ 214.8, 136.4, 134.8, 
134.0, 130.3, 128.4, 118.1, 87.3, 79.8, 76.5, 71.5, 64.6, 39.8, 38.1, 37.9, 35.0, 33.5, 30.1, 
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(2S,3S,4aS,6R,8S,9aR)-6-allyl-2-(3-((t-butyldiphenylsilyl)oxy)propyl)-3,9a-dimethyl-
8-((triethylsilyl)oxy)hexahydro-2H-pyrano[3,2-b]oxepin-7(3H)-one 1.155. To a 
solution of ketone 1.154 (240 mg, 0.450 mmol) in THF (12 mL) at rt was added TESCl 
(0.375 mL, 2.25 mmol) and Et3N (0.312 mL, 2.25 mmol). The reaction mixture was 
cooled to −78 °C and treated with LiHMDS (1.0 M in THF, 1.34 mL, 1.34 mmol). After 
being stirred at −78 °C for 50 min the reaction was warmed to rt and diluted with hexanes 
(10 mL). The diluted reaction mixture was loaded onto a plug of neutral silica gel eluting 
with 10:1 hexanes:EtOAC and then concentrated to afford crude enol silyl ether, which 
was used in the oxidation reaction without further purification. 
 To a solution of the above silyl enol ether in CH2Cl2 (5.0 mL) at rt was added 
NaHCO3 (0.188 g, 2.24 mmol) and mCPBA (0.077 g, 0.449 mmol). After 45 min, the 
reaction was quenched saturated aqueous NaS2O3 solution (5 ml). The aqueous phase was 
extracted with CH2Cl2 (3 x 20). The extracts were combined, dried (Na2SO4) and 
concentrated. Flash chromatography (hexane:EtOAc 20:1 to 10:1) gave 0.231 g (77 % 
yield) of 1.155 as a colorless oil. Rf  0.2 (10:1 hexanes/EtOAc); [α]D20 = +1.6° (c = 1.1, 
CH2Cl2);  1H NMR (500 MHz, C6D6) δ 7.84-7.76 (m, 4 H), 7.28-7.22 (m, 6 H), 5.89 
(dddd, J = 17.2, 10.3, 7.0, 7.0 Hz, 1 H), 5.09-5.01 (m, 2 H), 4.79 (dd, J = 12.1, 3.8 Hz, 1 
H), 3.85 (dd, J = 7.0, 5.4 Hz, 1 H), 3.76-3.63 (m, 2 H), 3.42-3.37 (m, 1 H), 3.05 (dd, J = 
12.1, 4.6 Hz, 1 H), 2.45-2.37 (m, 1 H), 2.18 (dd, J = 13.4, 3.9 Hz, 1 H), 2.10 (t, J = 12.3 
Hz, 1 H), 1.80-1.40 (m, 9 H), 1.29 (s, 3 H), 1.19 (s, 9 H), 1.06 (dd, J = 8.1, 7.7 Hz, 9 H), 
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118.4, 86.7, 79.7, 74.1, 71.1, 64.6, 50.8, 38.7, 34.5, 33.4, 30.6, 30.1, 29.6, 27.5, 19.8, 
15.8, 12.9, 7.5, 5.9. IR (film) 3400, 2933, 2849, 1731, 1462, 1428, 1110 cm-1; HRMS 




dioxolo[4,5-e]pyrano[3,2-b]oxepin-6-yl)propoxy)(tert-butyl)diphenylsilane 1.161. To 
a solution of 1.155 (.231 g, .363 mmol) in CH2Cl2 (5 mL) and MeOH (5 mL) at 0 °C was 
added CSA (ca .01 g). The reaction was stirred for 30 min at which point it was 
concentrated. The resulting residue was passed through a silica plug to give the crude 
hydroxy ketone 1.157 which was taken on into the reduction step without further 
purification.  
 To a solution of crude hydroxy ketone 1.157 (0.190 g, .345 mmol) from above in 
CH2Cl2 (6.5 mL) at -78 °C was slowly added iBu2AlH (0.605 ml of 1.5 M solution in 
toluene, .91 mmol). After stirring at this temperature for 45 min, a second portion of 
iBu2AlH (0.387 ml of 1.5 M solution in toluene, 0.58 mmol) was added.  The reaction 
was allowed to stir for an additional 45 min at -78 °C.  The reaction was quenched by the 
addition of saturated aqueous potassium sodium tartrate (10 mL). The resultant mixture 
was diluted with EtOAc and stirred at rt until the layers became clear. The aqueous phase 
was extracted with EtOAc (3 x 100 mL), dried (Na2SO4), and concentrated. Flash 
Chromatography (hexane:EtOAc 10:1) gave 0.175 g (92 % yield) of 1.159 as a colorless 
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acetonide:  Rf  0.30 (1:1 hexanes/EtOAc); [α]D20 = +8.3° (c = 0.07, CH2Cl2); 1H NMR 
(500 MHz, C6D6) δ 7.81-7.79 (m, 4 H), 7.25-7.23 (m, 6 H), 6.08 (dddd, J = 12.1, 10.3, 
6.7, 6.8 Hz, 1 H), 5.22-5.18 (m, 1H), 5.14-5.11 (m, 1H), 4.39 (ddd, J = 10.7, 6.6, 6.6 Hz, 
1H), 3.93 (dd, J = 9.7, 7.3 Hz, 1H), 3.71 (ddd, J = 10.0, 6.6, 6.6 Hz, 1H), 3.66 (ddd, J = 
10.0, 6.6, 6.6 Hz, 1H), 3.40 (m, 2H), 3.33 (dd, J = 12.2, 4.9 Hz, 1H), 2.74-2.70 (m, 1H), 
2.38 (dd, J = 13.2, 6.3 Hz, 1H), 2.35-2.30 (m, 1H), 2.06 (dd, J = 13.2, 10.7, 1H), 1.73-
1.44 (m, 5H), 1.43 (s, 3H), 1.23 (s, 3H), 1.95 (s, 9H), 0.95 (s, 3H), 0.76 (d, J = 6.84 Hz, 
3H); 13C NMR (125 MHz, C6D6) δ 136.4, 136.4 136.0, 134.8, 134.8, 130.3, 128.7, 117.1, 
108.4, 83.5, 81.7, 80.6, 74.9, 74.7, 70.9, 64.6, 45.3, 38.6, 34.6, 33.4, 30.2, 29.6, 28.0, 
27.5, 24.6, 19.8, 14.6, 13.2; IR (film) 2934, 2893, 1461, 1428, 1380, 1103 cm-1;  ESI/MS 
(m/z) calcd for C39H62O5Si2Na 689.7 (M+Na+), found 689.7; for C36H52O5SiNa 615.3482 
(M+Na+), found 615.3480. 
 
(2S,3S,4aS,6R,7S,8S,9aR)-6-allyl-8-(benzyloxy)-2-(3-((tert-butyl-diphenylsilyl)oxy)- 
propyl)-3,9a-dimethyloctahydro-2H-pyrano[3,2-b]oxepin-7-ol. 1.114 To a solution of 
diol 1.159 (0.015 g, 0.027 mmol) in MeOH (2.5 mL) was added Bu2SnO (.0074 g.030 
mmol). The reaction mixture was heated at reflux for 2.5 h and then cooled to rt. The 
solvent was evaporated and to the resulting residue was added DMF (1.25 mL) followed 
by CsF (0.007 mg, .041 mmol), then BnBr (0.030 mL, 0.041 mmol). The reaction was 
allowed to stir for 12 h. The reaction was loaded directly onto a column. Flash 
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monobenzyl coupling precursor 1.114 as a colorless oil. Rf 0.60 (3:1 hexanes:ethyl 
acetate). [α]D20 = +1.9° (c = 0.16, THF); 1H NMR (500 MHz, C6D6) 7.84-7.78 (m, 4H), 
7.30-7.14 (m, 10H), 7.10 (t, J = 7.3 Hz, 1H), 5.86 (dddd, J = 17.1, 10.2, 6.8, 6.8 Hz, 1H), 
5.03 (d, J = 15.1 Hz, 1H), 5.00 (d, J = 9.3 Hz, 1H), 4.40 (d, J = 12.2 Hz, 1H), 4.26 (d, J = 
11.7 Hz, 1H), 3.98-3.93 (m, 2H), 3.86 (ddd, J = 6.4, 6.4, 1.5 Hz, 1H), 3.75 (ddd, J = 10.3, 
6.4, 6.4 Hz, 1H), 3.70 (ddd, J = 9.8, 6.8, 6.8 Hz, 1H), 3.61 (d, J = 10.7 Hz, 1H), 3.45 
(ddd, J = 7.8, 4.4, 3.4 Hz, 1H), 2.56 (dd, J = 12.2, 12.2 Hz, 1H), 2.25-2.18 (m, 2H), 1.92 
(dd, J = 13.2, 2.0 Hz, 1H), 1.80 (m, 1H), 1.70-1.45 (m, 4H), 1.37-1.20 (m, 2H), 1.19 (m, 
9H), 1.16 (s, 3H), 0.92 (d, J = 6.8 Hz, 3H); 13C NMR (125 MHz, C6D6); 135.9, 135.0, 
134.4, 129.8, 128.5, 128.1, 127.9, 127.7, 117.0, 81.9, 76.9, 76.2, 74.5, 74.2, 70.7, 70.7, 
64.3, 41.3, 39.9, 34.5, 32.9, 29.8, 29.3, 27.0, 19.3, 16.3, 12.5; IR (neat) 3454, 2932, 2860, 






7,8-bis((triethylsilyl)oxy)octahydro-2H-pyrano[3,2-b]oxepin-6-yl)acid 1.177. To a 
solution of diol 1.159 (0.150 g, 0.287 mmol) in CH2Cl2 (15 mL) at 0 °C were added Et3N 
(1.0 mL, 4.30 mmol) and TESOTf (0.325 mL, 2.87 mmol). The reaction mixture was 
stirred at 0 °C for 1 h at which point the reaction was treated with saturated aqueous 
NaHCO3 (10 mL). The mixture was extracted with CH2Cl2 (4 x 20 mL). The extracts 
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through a plug of silica gel to give crude product, which used was in oxidation reaction 
without further purification.  
 To a solution of crude bis-TES (0.224 g, 0.287 mmol) from above in THF/t-
BuOH/H2O (5:5:1, v/v, 10 mL) at rt was added NMO (0.104 g, 0.896 mmol) and OsO4 
(0.360 mL of a 0.1 M soln. in THF, 0.036 mmol). The reaction mixture was stirred at 
room temperature for 6 h at which point saturated aqueous NaHCO3 (10 mL) was added. 
The aqueous phase was extracted with EtOAc (4 x 20 mL). The extracts were combined, 
dried (Na2SO4), and concentrated. The residue was passed through a plug of silica gel to 
give crude diol, which used was in the next reaction without further purification. 
To a solution of crude diol (0.208 g, 0.255 mmol) in benzene (15 mL) at rt was added 
Pb(OAc)4 (0.142 mg, 0.320 mmol). The reaction mixture was stirred at room temperature 
for 30 min and then concentrated. The resulting residue was passed through a pad of 
silica gel to give crude aldehyde, which used was in the next reaction without further 
purification.  
 To the crude aldehyde (0.195 g, 0.249 mmol) from above in tBuOH THF/t-
BuOH/H2O (1:1:1, v/v, 17 mL) at rt were added 2-methyl-2-butene (1.20 mL, 4.20 
mmol) followed by NaClO2 (0.095 g, 1.05 mmol) and NaH2PO4.H2O (0.125 g, 1.05 
mmol).  After stirring rapidly for 3 h the reaction mixture was diluted with sat. NH4Cl 
(aq., 10 ml). The aqueous phase was extracted with CH2Cl2 (6 X 25 ml). The extracts 
were combined, dried (Na2SO4) and concentrated. Flash chromatography (hexane:EtOAc 
10:1 to 3:1) gave 0.192 g (84% yield from 1.159)  of 1.177 as a colorless oil. Rf 0.30 (3:1 
hexanes:ethyl acetate). [α]D20 = -7.0° (c = 0.19, THF); 1H NMR (500 MHz, C6D6); 7.79-
7.75 (m, 4H), 7.26-7.21 (m, 6H), 4.31 (dd, J = 7.1, 7.1 Hz, 1H), 4.23 (dd, J = 10.7, 6.8 
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Hz, 1H), 4.03-3.99 (m, 2H), 3.68 (ddd, J = 10.3, 6.4, 6.4 Hz, 1H), 3.63 (ddd, J = 10.3, 
6.4, 6.4 Hz, 1H), 3.45-3.41 (m, 1H), 2.75 (dd, J = 12.0, 12.0 Hz, 1H), 2.59 (dd, J = 15.1, 
7.8 Hz, 1H), 2.40 (dd, J = 15.1, 6.8 Hz, 1H), 1.80-1.69 (m, 2H), 1.68-1.62 (m, 1H), 1.60-
1.45 (m, 3H), 1.34-1.27 (m, 2H), 1.26 (s, 3H), 1.16 (s, 9H), 1.09 (t, J = 7.8 Hz, 9H), 1.03 
(d, J = 8.3 Hz, 3H), 0.97 (t, J = 7.8 Hz, 9H), 0.72 (qd, J = 7.8, 2.0 Hz, 6H), 0.60 (qd, J = 
7.8, 2.0 Hz, 6H); 13C NMR (125 MHz, C6D6); 176.2, 135.8, 134.3, 134.2, 129.6, 128.1, 
81.3, 80.0, 73.9, 72.4, 70.6, 68.9, 64.1, 45.2, 39.7, 34.3, 32.9, 30.0, 29.6, 29.2, 26.9, 19.3, 
16.5, 12.2, 7.0, 6.9, 5.1, 4.9; IR (neat) 2955, 2878, 1713, 1464, 1426, 1382, 1107 cm-1; 
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             CHAPTER 2 
 
OLEFINIC-LACTONE CYCLIZATIONS: TOTAL SYNTHESIS OF  (-)- 
 
MUSCONE AND (+)-MUSCOPYRIDINE  
 
 
  Introduction 
Macrocyclic products are abundant in nature and the diversity in which nature has 
created marcocyclic systems has prompted synthetic chemists to develop equally diverse 
strategies in which to construct them. Common synthetic routes to such compounds often 
involve a macrocyclization step, which can prove challenging. Synthetic targets 
containing a lactone or lactam can readily be accessed through a macrolactonization or 
macrolactamization reaction.1 However, when synthesizing targets lacking these 
functionalities, synthetic chemists have been forced to turn to other, sometimes less 
obvious, disconnections to generate the macrocycle.2,3 In this chapter, studies illustrating 
the synthetic advances in the generation of all-carbon macrocycles will be discussed.   
Ring-closing metathesis has become a popular approach for the generation of all-
carbon macrocycles. Ring closing alkene metathesis (RCM) or ring closing alkyne 
metathesis (RCAM) are common methods to construct large rings including those of both 
natural and non-natural origins.4-8 Demonstration of RCM and RCAM in the total 
synthesis of the natural product civetone 2.1 is shown in Figure 2.1.9 
Grubbs’ first and second generation catalysts (Figure 2.2) used for RCM are 
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      Figure 2.1. Synthesis of civetone  via (a) RCM and (b) RCAM 
 
 




















































commercially available, easy to handle and stable at room temperature. The ruthenium 
based Grubb’s catalysts display high functional group tolerance, selectivity, and have 
proven useful under mild reaction conditions.5 
The Shrock molybdenum (VI) and tungsten (VI) based catalysts are known as 
Schrock alkylidenes. The Schrock catalyst system, tris-(tert-butoxy)-(2,2-dimethyl-
propylidyne)tungsten(VI) is also able to affect RCAM and related polymerizations.6,8,10 
Numerous studies on RCM have defined the scope of this method and have 
provided insights into the essential parameters required for successful macro ringclosing 
diene metathesis. Many successful synthetic endeavors have suggested the necessity of a 
properly positioned relay moiety (ester, ketone amide, etc.) to promote large ring 
cyclization. In Fürstner’s synthesis of lasiodiplodin, the success of the macrocyclization 
reaction is attributed to the coordination of the ester onto the ruthenium catalyst as shown 
in Figure 2.3.13 This coordination lowers the entropic energy barrier and/or the build up 
of ring strain associated with assembling the diene residues of 2.2. The distance between 
the diene residues and the ester are important parameters for the successful RCM of a 
macrocyclic ring.11,13	  
Relay moieties can often lead to difficulties in both the synthesis of the molecule 
as well as in the RCM reaction. More often than not, the relay moiety is imbedded within 
the macrocycle and unless the relay moiety can be removed following cyclization, the 
synthetic disconnection of all-carbon macrocycles may prove to be a difficult task. 
Chelation with the relay moiety can lead to a stable intermediate that can result in catalyst 
sequestering as shown in the synthesis of zeronal (Figure 2.4).13 When Fürstner and 
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obtained. This report, as with others, have indicated an incompatibility of Grubbs’ 
catalysts with substrates containing sulfur as well as various other donor sites.15,16   	  Due 
to these set backs, other methods have arisen to accommodate retrosyntheses lacking 
RCM to generate a macrocycle. Many examples exist; however, recent reports in the 
failure of RCM and the success of other methods to construct the macrocycle in 
kendomycin is representitive (Figure 2.5).17	  
 The diverse biological profile and challenging structure of kendomycin has inspired 
a number of groups to initiate a program towards its synthesis. To date, three total 
syntheses and one formal synthesis have been reported.18-22 The underlying problem for 
these approaches has been the formation of the strained macrocyclic ring through RCM 
and alternative disconnections have been required. For example, macrocyclizations were 
performed using C-glycosidation,18 Barbier-type addition,21 Prins reaction,22 and, perhaps 
most strikingly, all attempts to achieve macrocyclization at C13-C14 by ring-closing 
metathesis (RCM) have been unsuccessful due to low yields and formation of the 
undesired C13,C14-Z-olefin. Although the undesired Z olefin has, in some cases, been 
isomerized to the correct E olefin the transformation has required multiple steps after the 
initial RCM.20    
A creative disconnection of kendomycin was proposed by Mulzer et al. after they 
tested a variety of alternate locations for RCM disconnections that proved to be 
unsuccessful.17 They proposed a photo-Fries disconnection that required macrolactone 2.4 
as a key intermediate to construct the all carbon ansa-macrolide 2.5. The macrolactone 




Figure 2.5. Failure of RCM at C13 and C14 and success of a photo-Fries reaction to form 
































































underwent clean photo-Fries rearrangement to give the ketone 2.5 that was carried on to 
give kendomycin. In contrast to Furstner’s unsuccessful results, Mulzer was able to 
utilize a RCM strategy towards kendomycin (Figure 2.5), which again reemphasizes the 
ability of RCM for connecting diene residues.17 
Other natural products that have required methods alternative to RCM to achieve 
their synthesis include, bryostatin,24 epothilone,25,26 manzamine27 and countless others. All 
of these natural products required other means to construct their macrolide due to low 
yields or complete failure of RCM.  
 Aware of the difficulties associated with the synthesis of all-carbon macrocycles, 
we decided to investigate their formation using our previously disclosed reduced titanium 
ethylidene conditions that effect olefinic-ester metathesis.28 Central to the idea is the 
formation of a cyclic enol ether imbedded in a macrocycle through an olefinic-lactone 
cyclization, followed by its ring expansion to an all-carbon macrocycle.29    
Prior to our development of this methodology, our group employed a two-step 
sequence towards the generation of cyclic enol ethers (Figure 2.6).30,31 The acyclic enol 
ether was accessed via olefination of an ester using stoichiometric amounts of a titanium 
alkylidene reagent (ie. Tebbe’s reagent,32,33 Petasis reagent,34 and the Takai-Utimoto 
reagent35-37) and was subseuently subjected to RCM conditions using Grubbs’ or 
Schrock’s catalyst to give a cyclic enol ether.  Rainier et al. were the first to describe the 
use of Grubbs’ second generation catalyst to affect RCM of olefinic enol ethers.31 The 
two-step synthesis of enol ethers was proven to be an effective method to synthesize 







     
 















































































synthesize enol ethers would bypass the acyclic enol ether intermediate and some 
successes have been reported. 
Nicolaou and coworkers reported olefinic-ester cyclization reactions using the 
Tebbe and Petasis reagents to generate fused ether compounds (Figure 2.7).42,43 At the 
time, they proposed that cyclic enol ethers resulted from titanium alkylidene-mediated 
RCM of acyclic enol ether intermediates. Despite Nicolaou’s impressive one-step 
sequence, this method has been reported by a number of groups to give variable 
results.30,34 
More recently, Takeda and coworkers described the one-step generation of cyclic 
enol ethers from the corresponding thioacetal-esters using stoichiometric amounts of the 
titanium catalyst Cp2Ti[P(OEt)3]2 (Table 2.8).45 Their method delivers five-, six-, and 
seven-membered cyclic enol ethers in good yields from alkyl bis(phenylthio)alkanoates 
without oligomer formation. Impressively, ester 2.7 was transformed into the nine-
membered cyclic enol ether 2.8 with high stereoselectivity.  
Rainier and coworkers found that the in situ generated titanium-methylidene 
reagent could affect a one step olefinic-ester cyclization during model studes directed 
towards the synthesis of hemibrevetoxin B and gambierol.31,39,40 When compound 2.9 was 
treated with the titanium-methylidene reagent, a mixture of cyclic 2.10 and acyclic enol 
ether 2.11 in a 5:3 ratio was isolated (Figure 2.9). To disprove the possibility of a 
titanium alkylidene-mediated RCM of a transiently formed acyclic enol ether, 2.11 was 
isolated and resubjected to the titanium-methylidene reagent. This experiment failed to 
produce cyclic enol ether and led to the hypothesis that 2.10 was formed from a 
olefin/carbonyl metathesis pathway.   
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Interestingly, Rainier and Majumder found that the enol ether could be obtained  
directly when modifying the substrate to contain a sterically hindered ester (Table 2.10).46 
By incorporating a hindered ester, the titanium methylidene reagent would preferentially 
react with the olefin first followed by cyclization onto the carbonyl of the ester. As seen 
in the case of substrates 2.12 and 2.13 , the esters were significantly hindered compared 
to the olefins. When these substrates were subjected to the titanium methylidene reagent 
cyclic enol ether was isolated in >95:5 ratio. When a hindered olefin was employed, as 
with substrate 2.14, the titanium methylidene reagent was reactive towards the carbonyl 
first to give a mixture of acyclic enol ether and cyclic enol ether in a 1.3:1 ratio. The fact 
that we could bypass the acyclic enol ether intermediate by using a hindered ester was a 
significant step into understanding the mechanism of this transformation. 
Another significant discovery was made during Rainier and Dr. Scott Roberts’ 
work towards gamberic acid A.41 They found that a difference in the product distribution 
(acyclic vs. cyclic enol ether) could be controlled by utilizing a more substituted titanium 
alkylidene reagent (Figure 2.11). Upon the construction of the B ring of gamberic acid A 
using the titanium methylidene reagent, only the acyclic enol ether resulted. However, 
when the titanium ethylidene reagent was employed, the reaction led to the exclusive 
formation of cyclic enol ether 2.15. Much like the directed reactivity when using 
hindered esters to promote carbonyl-olefin metathesis, it was believed that the reactivity 
of the more substituted alkylidene was also due to steric interactions. 
It has been previously proposed that mixed metalloid species 2.16 and the 






       
 



























































































     
 









































CH3CHBr2 (50 % cyclic)
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that the mixed metalloid species is reactive towards carbonyls and the alkylidene species 
with olefins, we propose that the Keq of the equilibrium affects the product distribution 
(acyclic vs. cyclic enol ether).47-49 When the dibromoalkane source used to generate 2.16 
is unsubstituted, as in the case of dibromomethane, the equilibrium lies to the left 
favoring the formation of the mixed metalloid species 2.16, and thus produces acyclic 
enol ether. However, when substitution is incorporated on the dibromoalkene source, 
such as dibromoethane, the mixed metalloid formation is disfavored, presumably due to 
steric interactions with ligands on Ti or through the stablization of the alkylidene thereby 
favoring titanium ethylidene formation 2.17 (Figure 2.12).28 
The fact that cyclic material could be generated exclusively by utilizing a more 
substituted titanium alkylidene reagent was unprecedented. Dr. Karthik Iyer 
subseuentially investigated the scope of the reaction and has found it to be applicable to a 
broad range of substrates (Table 2.13). 
We had previously examined the reaction of 2.9 with the titanium methylidene 
reagent and had found it to give a mixture of products (Figure 2.9).30 However, when 2.9 
was subjected to the titanium ethylidene reagent, we isolated cyclic enol ether 2.10 as the 
only identifiable product in 75% yield (entry 1). More challenging cyclization substrates 
that lacked a cyclic template were also subjected to the titanium ethylidene reagent 
(entries 2-4).28 In all cases, only cyclic enol ethers were obtained in good yield. 
Dr. Iyer’s work has since led to the investigation of using the titanium ethylidene 
reagent to affect two-directional olefinic-ester metathesis. The idea was inspired by the 
symmetrical nature of the natural products and other efficient two-directional approaches 
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Colleague Yuan Zhang found that use of the titanium ethylidene reagent allowed 
for the rapid construction of polycyclic ether natural products through utilization of 
substrates that allow for two enol ethers to be formed in a single flask from a bis-olefinic-
ester.55 As shown in Table 2.14, the method allowed rapid entry into polyether skeletons. 
Currently, colleague Dr. Xin Hao is using this transformation as a tool to synthesize des-
methyl analogues of gamberiol (Figure 2.15). 
After the development of the aforementioned olefinic-ester cyclizations, we 
became intrigued that the use of a reduced titanium reagent may also affect olefinic-
amide cyclizations (Table 2.16). Precedent for this transformation was illustrated in 
Bennasar’s work involving the initial conversion of amides into mixtures of cyclic and 
acyclic enamides using Tebbe’s reagent.56 The mixture was then converted into cyclic 
enamides using Grubbs’ second generation catalyst.  Using Bennasar’s chemistry as 
impetus, colleague Dr. Jie Zhou found that the olefinic-amide cyclization was applicable 
to the synthesis of four- and six- membered enamines from the corresponding 3-
substituted azepanones.57 When Zhou employed different aromatic olefinic-lactam 
substrates, indole and dihydroquinoline skeletions were efficently formed (entries 3 and 
4, respectively).  
 
Results and Discussion 
 Combining our experience with olefinic-ester and olefinic-amide/lactam 
cyclizations we became interested in studying olefinic-lactone cyclizations. Described 
herein is the successful use of the titanium ethylidene reagent in this context.29 We 
















































 Zn, PbCl2, CH3CHBr2
 CH2Cl2, reflux

























   
 
 
                 
 
 
































































H H H H H








    
 








 Zn, PbCl2, CH3CHBr2
 CH2Cl2, reflux























ansa-dihydropyran macrolide 2.19 (Figure 2.17).  The olefinic-lactone was generated in 
three steps from commercially available 2.20. The conversion included oxidation, 
Grignard addition, and lactonization. To our delight, when 2.18 was subjected to the 
titanium ethylidene reagent, 2.19 was isolated as the sole product in quantitative yield. To 
the best of our knowledge, similar transformations have not been demonstrated prior to 
this work. Thus, we set out to investigate the scope of the reaction.  
 Various olefinic-lactones were synthesized with variation of the length of the olefin 
linker and lactone size (Figure 2.18). Rapid access to the cyclization precursors was 
necessary to be able to direct our focus to the olefinic-lactone cyclization. A variety of 
commercially available seco-acids with pendant primary alcohols could be oxidized to 
the aldehyde without the need to protect the carboxylic acid. Initially, we screened 
DMSO-mediated oxidations and found that the electrophilic intermediates produced in 
the reaction alkylated the carboxylic acid and led to undesired byproducts. We then chose 
to look at oxidations mediated by hypervalent iodine, namely Dess-Martin periodinane 
and iodoxybenzoic acid (IBX).58 When employing the Dess-Martin reagent, conversions 
to the aldehyde were low, which is perhaps due to the limited solubility of the seco-acids 
in CH2Cl2. Alternatively, when IBX was used in the more polar solvent, DMSO, 
quantitative conversions to the aldehyde were observed. Once the reaction was complete, 
a simple aqueous workup provided the crude acid-aldehyde that was subjected to an 
excess of Grignard reagent to give the corresponding olefinic seco-acid 2.22. The 
variation of the alkene linker length was achieved through the addition of either butenyl 
or pentenyl magnesium bromide to the aldehyde. The olefinic seco-acids were subjected 
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membered lactones.59 High yields in the case of the 16-membered lactones (2.23 and 
2.25) were obtained when the mixed anhydride was added over 12 hrs to a dilute solution 
of DMAP in toluene at 45oC.60 Employing these same conditions, moderate 
macrolactonization yields were observed in the formation of the medium-sized 13- 
membered ring (Figure 2.17, 2.18). This is likely due to ring strain as the corresponding 
dimer was observed as a byproduct. 
 We also decided to embed an amine in the macrocycle to see if the titanium 
ethylidene reagent would be compatible with a Lewis basic site within the substrate. 
Toward this end, we set out to synthesize the benzyl-amine containing substrate 2.30 
(Figure 2.19). 
 The synthesis commenced with reductive amination between known aldehyde61 
2.26 and amine 2.27 followed by TIPS deprotection and ester hydrolysis to give the seco-
acid 2.29. Yamaguchi macrolactonization provided the olefinic-lactone 2.30. With the 
substrate syntheses complete, we investigated their cyclizations using the titanium 
ethylidene reagent.   
 We found that the scope was indeed general with respect to lactone size, as 
dihydropyran formation was successful with 16- membered lactones, 2.23 and 2.25 to 
give the 6-membered 2.31 and 7-membered 2.33 ansa-macrolides, respectively (Table 
2.20). The benzylamine containing lactone 2.30 also underwent smooth conversion to 
2.32 in 69% yield. Notably, in all cases, only cyclic material was obtained when the 
titanium ethylidene reagent was employed. 
 The enol ethers generated in these cyclization reactions are precursors to a number 
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products towards the synthesis of more elaborate substrates, we decided to exploit the 
inherent reactivity of the enol ethers.  With this in mind, hydrolysis of cyclic enol ether 
2.31 with silica gel gave the ring-expanded all-carbon macrocycle (Figure 2.21). The 
resulting hydroxyketone was then treated with benzoic anhydride and the resulting ester 
2.34 was isolated in 63% yield from lactone 2.23. Alternativly, 2.31 was then treated with 
mCPBA in anhydrous MeOH to give mixed ketal 2.35 in 68% yield.38 Lastly, reduction 
of the enol ether using Et3SiH and TFA produced the σv symmetric pyran 2.36 as a single 
diasteromer.  
 As a further illustration of the utility of this method, we applied the lactone 
formation/reduced Ti mediated cyclization/ring expansion sequence to the synthesis of 
the natural products (R)-(-)-muscone and (R)-(+)-muscopyridine.29  
 
 
Synthesis of (R)-(-)-muscone and (R)-(+)-muscopyridine 
 
 The organic compound primarily responsible for the characteristic odor of musk is 
muscone and may be obtained naturally from the glandular secretions of the male musk 
deer (Moschus moschiferus) that is native to central Asia.62 The odoriferous secretion 
functions as a sex pheromone for the deer and is one of the oldest-known ingredients of 
perfumes.  Harvesting the secretions results in the death of the animal and, because of 
muscone’s large demand, the musk deer population diminished leading to their 
classification as “endangered”.62 Synthetic production of muscone became an attractive 
solution that could prevent the extinction of the musk deer and provide unliminted 
quantities of muscone. One method, common to the perfumery industry for the synthesis 














                    
 
Figure 2.21. Reactions of enol ether 2.27 to provide various macrocycles. 





























expensive method of C-C bond formation.63, 64 The gas phase intramolecular aldol 
reaction of 2,15-hexadecadione 2.37 using metal oxides as catalysts is an efficient, cheap 
method to produce racemic muscone (Figure 2.22).63 The racemic muscone differs only 
slightly in scent, having a slightly lower odor threshold than the enantiopure material.62 
Most syntheses of optically active muscone involve RCM or RCAM that require high 
dilutions, which is impractical for industral production.63,65,66 
Another unique synthesis of rac-muscone was completed by Eschenmoser and 
coworkers and employs the Eschenmoser fragmentation reaction was a key step (Figure 
2.2).67 The synthesis commences with the epoxidation of bicyclic ketone 2.39 with 
hydrogen peroxide under basic conditions, followed by addition of methane 
sulfonylhydrazine to the ketone to generate hydrazone 2.40. The Eschenmoser 
fragmentation is then initiated through the deprotonation of the hydrazone to generate 
alkyne 2.41 and N2. The alkyne 2.41 was easily reduced to produce rac-muscone. 
Eschenmoser’s oxidation/ring-expansion strategy as a means to produce the all-carbon 
macrocyclic ring is conceptually similar to our own work as outlined below (Figure 2.23 
and 2.24). 
 Our method utilizes an olefinic-lactone cyclization/ring expansion method 
towards the synthesis of muscone and its cognate natural product, muscopyridine. Our 
synthesis of both molecules began from aldehyde 2.42 which was subjected to the 
Horner-Wadsworth-Emmons (HWE) reagent derived from (R)-phenylglycine 2.43. The 
HWE reagent was prepared from the corresponding bromoacetyl oxizolidone through a 
Michaelis-Arbuzov reaction using triethylphosphite.68 The HWE reaction served to 
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derived auxiliary required for the asymmetric Michael addition. Methyl cuprate addition 
to unsaturated oxazolidinone 2.44 using Hruby’s method proceeded smoothly to give 
2.45 as essentially a single diasteriomer (d.r. > 20:1) in 69% yield.69  Oxidative removal 
of the benzyl group using DDQ gave the corresponding secondary alcohol. Liberation of 
the acid through hydrolysis of the oxazolidinone produced olefinic seco-acid 2.46. 
Yamaguchi macrolactonization of 2.46 gave 13-membered olefinic-lactone cyclization 
precursor 2.47 in good yield. The dihydropyran 2.48 was smoothly formed upon the 
subjection of 2.47 to the titanium ethylidene reagent. Ring expansion of the macrocyclic 
dihydropyran 2.48 using silica gel gave the hydroxyketone 2.49, which served as a 
precursor to both muscone and muscopyridine. (R)-(-)-Muscone was synthesized through 
a Barton-McCombie deoxygenation of 2.49, whereas (R)-(+)-muscopyridine resulted 
from the oxidation of the secondary alcohol in 2.49 to give the diketone 2.50.70 The 
diketone was subjected to pyridine formation conditions that employ hydroxylamine 
hydrochloride in ethanol at 165 0C to give (R)-(+)-muscopyridine.71 Spectral data of (R)-
(-)-Muscone and (R)-(+)-muscopyridine matched in all respects with that of literature 
reported samples.66,71 In summary, we have described a unique and efficient approach to 
all-carbon macrocycles that utilizes an olefinic-lactone cyclization reaction as the key 
step. Application of our method to the synthesis of the natural products (R)-(-)-muscone 
and (R)-(+)-muscopyridine has been achieved.  
Conclusion 
In continuation of our study of the scope of this reaction, we plan on utilizing the 
olefinic-lactone cyclization to expedite the synthesis of polycyclic ether analogues. Our 
current strategy to synthesize the 6, 7- bicycle 2.58 that is common to hemibrevetoxin B 
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and gambierol syntheses involves 18 steps from commercially available D-
glyderaldehyde.31,39,40 It is believed that the synthesis can be shortened to 9 steps by 
employing an olefinic-lactone cyclization as shown in Figure 2.25. The second-
generation approach would commence with the synthesis of key intermediate, hemiketal 
2.52 that is believed to be available from cyclohexenone 2.51 in three steps using known 
chemistry.72 A Grob-type fragmentation of 2.52 using hypervalent iodine is expected to 
generate the olefinic-lactone 2.53 that contains a “Z” olefin. Olefinic-lactone cyclization 
gives the ansa-dihydropyran 2.54 to which a selective DMDO epoxidation/AlMe3 
addition would be carried out to give 2.55. Ozonylitic cleavage of the olefin is expected 
to deliver dialdehyde 2.56. The dialdehyde would then be subjected to an acid mediated 
cyclization/elimination to provide oxepene 2.57 after olefination. Another DMDO 
oxidation/allyl Gringard addition would provide the desired the 6,7- bicycle 2.58. 
 
Alkyne-Ester Cyclizations 
  In addition to olefinic-lactone and olefinic-amide cyclizations, we sought 
to investigate the synthesis of tetra-substituted enol ethers through alkyne-ester 
metathesis. The formation of tetra-substituted enol ethers from the corresponding acyclic 































































the formation of tetrasubstituted olefins using Grubbs-type complexes is challenging 
(Table 2.26).73,74 The conversions of entries 1-3 were low when the RCM was carried out 
using either Grubbs’ second generation or the Hoveyda-Grubbs’ catalysts.74 In addition to 
the low yields from these transformations, the prolonged reaction times at high 
temperatures leads to decomposition of the catalyst.74  
 In contrast to these results, ene-yne metatesis that utilizes a platinum (II) species to 
generate tetrasubstituted enol ethers is efficient.78 Enyne metathesis is a bond 
reorganization of an alkene and an alkyne to produce a 1,3-diene (Figure 2.27). 
Mechanisitic work by Furstner and coworkers showed that activation of the alkyne by 
Pt(II) coordination leads to oxonium ion formation, which results in the release of the 
allyl carbocation.78,79 Allyltransfer to the electron rich carbon-platinum bond generates 
the tetrasubstituted enol ether. The yields are generally good for these types of reactions, 
however E,Z mixtures that result from non selective allyl transfer to the cationic 
intermediate typically occur. In the examples shown in Table 2.27, a single alkene isomer 
was produced.  
          Similar to these results, if alkyne-ester cyclizations were successful they would 
also generate a tetra-substuted enol ether. Utilizing the titanium ethylidene reagent would 
be substantially cheaper than Grubbs’ catalyst, it may be generated in situ and exhibits 
lower Lewis acidity relative to other titanium alkylidenes. In addition to the tetra-
substituted olefin that would result from an alkynyl-ester cyclization, a 1,3-diene would 
also be formed from the reaction. We believed the generation of the tetrasubstituted 
olefins would be driven by the enthalpic stability of the conjugated 1,3-diene. In any 







                           
 
Table 2.26. Generation of cyclic tetrasubstituted olefins using Grubbs’ second generation 













































	  	  	  	  	  
	  	  	  




























Various alkynyl-ester substrates were synthesized that included both cyclic and 
acyclic templates. We were able to rapidly access cyclization precursors 2.67 and 2.70 
though chemistry that has been previously established in our laboratories from the known 
D-glucal derived starting materials 2.65 and 2.68, respectively (Figure 2.28).30 After 
oxidation of 2.65 with dimethyl dioxirane (DMDO) to generate the corresponding 
epoxide, propargyl magnesium bromide was added to achieve carbon-carbon bond 
formation that led to exclusive formation of the β-C-glycoside 2.66 in 72% yield. The 
secondary alcohol of 2.66 was subsequently acylated to give cyclization precursor 2.67. 
The synthesis of 2.70 proceeded in an analogous fashion from 2.68. In addition to the 
propargyl β-C-glycosides 2.67 and 2.70 we thought that the substrate scope should 
contain an acyclic template alkynyl-ester and 2.73 was prepared from known aldehyde 
2.7128 through a Grignard addition of the homo-propargyl species 2.7277 followed by 
TMS cleavage and acylation of the secondary alcohol.  
With the substrates in hand, we initially turned our attention to their cyclization 
using the titanium ethylidene reagent derived from dibromoethane (Table 2.29). When 
2.67 was subjected to these conditions, we isolated a complicated mixture of products. 
Crude 1H NMR analysis indicated that the desired product was formed, however a 
significant amount of unidentified byproducts were present, which we were unable to 
separate via chromatography. In addition, the crude yield was low. Similar results were 
obtained when 2.70 was subjected to the titanium ethylidene reagent.  
When the more challenging alkyne-ester substrate 2.73 was employed complete 
decomposition of the starting material was observed. Discouraged by these results, we  
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DMDO, CH2Cl2, -78 oC to 0 oC;
THF, BrMg 0 
oC to rt
Ac2O, DMAP, (i-Pr)2NEt
0 oC to rt
98%
72%
DMDO, CH2Cl2, -78 oC to 0 oC;




0 oC to rt
98%
THF, 0 oC to rt
1)
2) K2CO3, MeOH, rt
3) Ac2O, DMAP,  (i-Pr)2NEt























































TiCl4, THF, TMEDA, Zn, PbCl2























elected to employ a titanium methylidene reagent to affect alkynyl-ester cyclization of the 
hindered substrate 2.67. Previous studies in our group indicated that the titanium 
methylidene reagent was able to affect olefinic-ester cyclizations when the ester was 
hindered.46 Using these results as impetus, we subjected substrate 2.67 to the titanium 
methylidene reagent and were delighted to isolate the tetrasubstituted enol ether 2.74 in 
63% yield. This preliminary result indicated that the titanium-methylidene reagent could 
indeed induce alkyne-ester metathesis.  
  To our knowledge, we have demonstrated the first alkyne-ester metathesis 
reaction.  The results indicate that optimization is required to fully realize the potential of 
this unique transformation.  Advancement in alkynyl-ester metathesis might include the 
determination of the byproducts, which were formed in the above reactions; as this may 
provide insight as to what the problem of the reaction may be. Also, a better understanding 
of the titanium ethylidene reagent would likely facilitate its optimization. Optimization 
might include the exploration of ligand substitution on the mixed metalloid species that 
leads to the alkylidene species. For example, we could investigate the use of different 
amines other than tetramethylethylenediamine: perhaps by changing the sterics about 
the titanium reagent, we can tune its reactivity for optimization. Also, the affect of leaving 
groups other than 1,1-dibromides will be examined in hopes to better understand the 
reactivity of the titanium alkylidene species.    
 
Supporting Information  
General Experimental Procedures 
Unless otherwise noted, all reactions were performed under a nitrogen atmosphere in 
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flame-dried glassware. NMR spectra were recorded on a Varian VXR-500 MHz 
spectrometer. Chemical shifts were reported in δ, parts per million (ppm), relative to 
benzene (7.16), dichloromethane (5.32) or chloroform (7.27) as internal standards. 
Coupling constants, J, were reported in Hertz (Hz) and refer to apparent peak 
multiplicities. IR spectra were recorded on a Bruker Tensor 27 FT-IR spectrometer. Mass 
spectra were recorded at the Mass Spectrometry Facility at the Department of Chemistry 
of the University of Utah at Salt Lake City on a Finnigan MAT 95 mass spectrometer. 
Dichloromethane, TMEDA and pyridine were dried by distillation from calcium hydride 
and saturated with nitrogen. Tetrahydrofuran and diethyl ether were dried from the sodium 
ketyl of benzophenone and distilled before use. Zinc dust (<10 μm, Aldrich) was activated 
by washing with 5% hydrochloric acid, H2O, ether, and acetone and dried in vacuo 
overnight. The activated zinc was stored under nitrogen in a dessicator. All other reagents 
were used without further purification unless otherwise noted. Analytical thin–layer 
chromatography (TLC) was performed on silica gel plates (0.25 mm) precoated with a 
fluorescent indicator. Flash chromatography was performed using 40–63 μm silica gel 
(200 X 400 mesh).  
 
 
12-hydroxyhexadec-15-enoic acid (2.21). To a solution of 12-hydroxydodecanoic acid 
(0.220 g, 1.01 mmol) in DMSO (2.20 mL) at rt was added IBX (0.340 g, 1.21 mmol). 
After stirring for 4 h the reaction mixture was diluted with ether (50 mL) and the reaction 





dried (MgSO4), and concentrated to afford the corresponding aldehyde (12-
oxododecanoic acid) as a white solid. The aldehyde was used in the next reaction without 
additional purification.  
A solution of 4-bromo-1-butene (1.01 mL, 10.0 mmol) in THF (10 mL) was 
added to Mg turnings  (0.680 g, 20.0 mmol) over 1 h at rt. The slurry was allowed to stir 
for an additional hour before being transferred to a solution of the crude aldehyde from 
above (1.01 mmol) in THF (4.6 mL) at 0 °C.  After 1 h the reaction was quenched with 
sat. NH4Cl (aq., 10 mL) and the resulting mixture diluted with Et2O (50 mL). The 
organic phase was washed with brine (50 mL), dried (Na2SO4), and concentrated. Flash 
chromatography (hexanes:ethyl acetates, 10:1 to 5:1 to 1:1) gave 195 mg of seco-acid 
2.21 (71%) as a white, waxy solid. mp 40-41 °C; Rf = 0.32 (1:1 EtOAc/hexanes);  1H 
NMR (500 MHz, CDCl3) δ 5.85 (dddd, J = 16.9, 10.1, 6.6, 6.6 Hz, 1H), 5.03 (ddd, J = 
17.2, 3.6, 1.6 1H), 4.96 (dddd, J = 10.1, 2.0, 1.3, 1.3 Hz, 1H), 3.66-3.60 (m, 1H), 2.33 (t, 
J = 7.5 Hz, 2H), 2.25-2.06 (m, 2H), 1.66-1.27 (m, 22 H); 13C NMR (125 MHz, CDCl3) δ 
179.8, 138.8, 114.9, 71.8, 37.5, 36.5, 34.3, 30.2, 29.8, 29.7, 29.6, 29.5, 29.3, 29.2, 25.7, 
24.9; IR (neat) 3500-2500 (broad), 2918, 2850, 1696, 1465, 1440, 1249, 1217, 1120 cm-1; 
LRMS m/z calcd for C16H31O3  (MH)+ 271.1, found: 271.0. 
 
13-(but-3-enyl)oxacyclotridecan-2-one (2.18). To a solution of seco-acid 2.21 (0.100 g, 




mmol) and 2,4,5-trichlorobenzoyl chloride (0.057 mL, 0.37 mmol). After 5.5 h, the 
reaction mixture was diluted with toluene (185 mL) and transferred over a period of 6 h 
to a solution of DMAP (0.271 g, 2.22 mmol) in toluene (37 mL) at 48 ºC. After the 
addition was completed the reaction mixture was stirred for an additional 2 h after which 
it was cooled to rt and concentrated. Flash chromatography (hexanes:ethyl acetate, 100:1 
to 50:1) gave 70 mg of macrolactone 2.18 (75 %) as a brown oil. Rf 0.63 (10:1 
hexanes/EtOAc); 1H NMR (500 MHz, CDCl3) δ 5.75 (dddd, J = 16.8, 10.2, 6.6, 6.6 Hz, 
1H), 5.02 (ddd (J = 17.2, 3.4, 1.8 Hz, 1 H), 4.98-4.93 (m, 2H), 2.44 (ddd, J = 13.9, 8.4, 
3.5 Hz, 1H), 2.26 (ddd, J = 13.8, 9.4, 3.5 Hz, 1H), 2.10-2.04 (m, 2 H), 1.76-1.53 (m, 6 
H), 1.47-1.26 (m, 14 H); 13C NMR (125 MHz, CDCl3) δ 174.0, 138.2, 115.0, 74.1, 35.2, 
34.2, 33.5, 30.0, 27.0, 26.6, 26.2, 25.2, 25.0, 24.8, 24.7, 22.8. IR (neat) 2931, 2860, 1731, 
1447, 1249, 1099 cm-1; LRMS  m/z calcd for C16H28O2 (MH)+ 253.2, found: 253.1. 
 
16-oxabicyclo[10.3.1]hexadec-12-ene (2.19). TiCl4 (0.31 mL, 2.8 mmol) was added to 
CH2Cl2 (10 mL) at 0 °C. To the resulting solution was sequentially added THF (1.2 mL, 
14 mmol) and TMEDA (2.06 mL, 13.7 mmol) dropwise. The ice bath was removed and 
the mixture was allowed to stir for 20 min. Activated Zn dust (0.333 g, 5.13 mmol) and 
PbCl2 (0.075 g, 0.27 mmol) were added at once. The resulting mixture went through a 
series of color changes from brown to green to purple and finally to blue-green over the 
course of 3-5 min. To the blue-green slurry was added a solution of macrolactone 2.18 
O
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(0.018 g, 0.071 mmol) and CH3CHBr2 (0.20 mL, 2.3 mmol) in CH2Cl2 (1 mL + 1 mL 
rinse). The reaction mixture was then heated at 65°C for 2 h, cooled to 0 °C, and the 
reaction was quenched with sat. K2CO3 (aq., 2 mL). After stirring for 0.5 h at 0 °C, the 
resulting mixture was filtered (1:1 hexanes:EtOAc) and the filtrate was concentrated. The 
residue was taken up in EtOAc and to this was added SiO2 (ca 0.250 g). After 
concentration the resulting solid was loaded onto a silica gel column and eluted with 
hexanes:ethyl acetate (100:1 to 20:1) to give 13 mg of cyclic enol ether 6 (87%) as a clear 
yellow oil. Rf 0.85 (10:1 hexanes/EtOAc); 1H NMR (500 MHz, CDCl3) δ 4.60 (m, 1H), 
3.86-3.81 (m, 1H), 2.26-2.16 (m, 4 H), 2.10-2.02 (m, 2 H), 2.00-1.93 (m, 2H), 1.82-1.62 
(m, 16 H); 13C NMR (125 MHz, C6D6) δ 155.5, 95.7, 74.8, 34.3, 34.0, 30.5, 28.4, 27.3, 
27.3, 27.2, 26.7, 26.5, 25.7, 23.6, 21.1; IR (neat) 3061, 2928, 2858, 1674, 1463, 1261, 
1092, 1023 cm-1; LRMS m/z calcd for C15H27O (MH)+ 223.2, found 223.3. 
 
16-hydroxyicos-19-enoic acid. (2.20) Prepared according the general procedure 
described above for the preparation of 2.21 using 16-hydroxyhexadecanoic acid (0.300 g, 
1.10 mmol), DMSO (2.2 mL), IBX (0.340 g, 1.21 mmol), and butenyl magnesium 
bromide (12 mL of a 0.83 M solution in THF, 10 mmol) to give 233 mg of seco-acid 2.20  
(65%) as a white, waxy solid. mp 57-61 °C; Rf = 0.45 (1:1 EtOAc/hexanes); 1H NMR 
(500 MHz, CDCl3) δ 5.85 (dddd, J = 17.0, 10.3, 6.6, 6.6 Hz, 1H), 5.05-4.99 (m, 1H), 
4.98-4.94 (m, 1 H), 3.64-3.59 (m, 1H), 2.35 (t, J = 7.4 Hz, 2 H), 2.12-2.04 (m, 2 H), 1.64 






138.9, 114.9, 71.8, 37.7, 36.7, 34.3, 34.1, 30.3, 29.9, 29.8, 29.8, 29.7, 29.6, 29.4, 29.2, 
29.2, 25.8, 25.5, 24.9 MHz; IR (neat) 3400-2600 (broad), 2917, 2849, 1700, 1433, 1261, 
911 cm-1; LRMS m/z calcd for C20H37O3 (M-H+)- 325.3, found: 325.4.  
 
17-(but-3-enyl)oxacycloheptadecan-2-one, (2.23). Prepared according to the general 
procedure using seco-acid 2.22 (67 mg, 0.22 mmol) in THF (7.3 mL) and Et3N (0.080 
mL, 0.57 mmol), 2,4,5-trichlorobenzoyl chloride (0.045 mL, 0.28 mmol), toluene and 
THF (3:1, 50 mL), and a solution of DMAP (532 mg, 4.36 mmol) and toluene (120 mL) 
to give 60 mg of macrolactone 2.22 (90%) as a clear colorless oil. Rf 0.20 (50:1 
hexanes/EtOAc);  1H NMR (500 MHz, CDCl3) δ 5.80 (dddd, J = 16.6, 10.3, 6.4, 6.4 Hz, 
1H), 5.01 (ddd, J = 17.1, 3.0, 1.5 Hz, 1 H), 4.98-4.94 (m, 2 H), 2.37-2.27 (m, 2H), 2.09-
2.02 (m, 2H), 1.75-1.52 (m, 6 H), 1.36-1.26 (m, 22 H); 13C NMR (125 MHz, CDCl3) δ 
173.9, 138.2, 115.0, 73.7, 34.9, 34.6, 34.0, 30.0, 28.5, 28.5, 28.4, 27.9, 27.8, 27.1, 27.1, 
27.1, 26.8, 25.2, 24.8; IR (neat) 2928, 2857, 1734, 1458, 1109 cm-1; LRMS m/z calcd for 
C20H36O2 309.3 (MH)+, found 309.3. 
 
Oxabicyclo[14.3.1]icos-1(19)-ene, (2.31). Prepared according to the general procedure as 







mmol), THF (1.5 mL, 17 mmol), TMEDA (2.6 mL, 17 mmol), activated Zn dust (0.41 g, 
6.3 mmol), PbCl2 (0.092 g, 0.33 mmol), and a solution of macrolactone 2.23 (0.027 g, 
0.087 mmol) and CH3CHBr2 (0.25 mL, 2.8 mmol) in CH2Cl2 (1.2 mL + 1.2 mL rinse) to 
give 20. mg of cyclic enol ether 2.31 (83%) as a clear yellow oil. 1H NMR (500 MHz, 
C6D6) δ 4.52 (dd, J = 4.0, 3.4 Hz, 1H), 3.70 (dddd, J = 8.8, 8.8, 2.9, 2.9 Hz, 1 H), 2.16-
2.05 (m, 2H), 2.03-1.95 (m, 2H), 1.91-1.85 (m, 2H), 1.63-1.30 (m, 26H); 13C NMR (125 
MHz, C6D6) δ 155.3, 95.3, 75.4, 35.8, 35.5, 29.1, 28.6, 28.7, 28.1, 28.1, 28.0, 27.9, 27.7, 
27.6, 25.6, 21.2; IR (neat) 2926, 2856, 1675, 1459, 1235, 1068 cm-1; LRMS m/z calcd for 
C19H35O (MH)+ 279.2, found 279.2.  
 
4-benzyl-2-(but-3-enyl)-1-oxa-4-azacyclohexadecan-16-one (2.30). Prepared according 
to the general procedure as described for the preparation of 2.18 using 16-(benzyl(2-
hydroxy-1-phenylhex-5-enyl)amino)hexadecanoic acid (0.035 g, 0.090 mmol), THF (3.0 
mL), Et3N (0.032 mL, 0.23 mmol), 2,4,5-trichlorobenzoyl chloride (0.019 mL, 0.12 
mmol), toluene:THF (3:1, 50 mL), and a solution of DMAP (0.22 g, 1.8 mmol) in toluene 
(100 mL) to give 15 mg of macrolactone 2.30 (43%) as a clear yellow oil. Rf 0.65 (10:1 
hexanes/EtOAc); 1H NMR (500 MHz, CDCl3) δ 7.33-7.22 (m, 5 H), 5.76 (dddd, J = 
17.1, 10.2, 6.8, 6.8 Hz, 1H), 5.17-5.13 (m, 1H), 5.00-4.92 (m, 2H), 3.85 (d, J = 13.6 Hz, 
1H), 3.24 (d, J = 13.7 Hz, 1H), 2.68 (dd, J = 13.7, 8.8 Hz, 1 H), 2.64 (ddd, J = 12.7, 7.3, 





19H); 13C NMR (125 MHz, CDCl3) δ 173.8, 140.0, 138.1, 129.2, 128.2, 127.0, 115.0, 
71.2, 59.1, 57.8, 54.4, 34.3, 32.2, 29.8, 27.3, 27.1, 27.0, 26.4, 26.2, 26.0, 26.0, 25.4, 24.0; 
IR (neat) 2927, 2856, 1731, 1453, 1071 cm-1; LRMS  m/z calcd for C25H40NO2 (MH)+ 
386.2, found 386.1.  
 
3-benzyl-19-oxa-3-azabicyclo[13.3.1]nonadec-15-ene (2.32). Prepared according to the 
general procedure as described above for the preparation of 6 using TiCl4 (0.091 mL, 
0.83 mmol) in CH2Cl2 (3.8 mL), THF (0.438 mL, 5.00 mmol), TMEDA (0.755 mL, 5.00 
mmol, activated Zn dust (0.122 g, 1.87 mmol), PbCl2 (0.028 g, 0.099 mmol), and a 
solution of macrolactone 2.19 (0.010 g, 0.026 mmol) and CH3CHBr2 (0.075 mL, 0.83 
mmol) in CH2Cl2 (0.35 mL + 0.35 mL rinse) to give 6.4 mg of cyclic enol ether 2.32 (69 
%) as a clear yellow oil. Rf 0.40 (20:1 hexanes/EtOAc); 1H NMR (500 MHz, CD2Cl2) δ 
7.38 (d, J = 7.4 Hz, 2H), 7.28 (t, J = 7.3 Hz, 2H), 7.21 (t, J = 7.1 Hz, 1H), 4.45 (broad s, 
1H), 3.89 (broad s, 1H), 3.68 (d, J = 14.1 Hz, 1H), 3.50 (d, J = 13.7 Hz, 1H), 2.71 (dd, J 
=  13.2, 7.3 Hz, 1H), 2.62-2.58 (m, 1H), 2.53-2.51 (m, 1 H), 2.40 (broad dd, J = 13.7, 3.0 
Hz, 1 H), 2.09-1.89 (m, 4H), 1.68-1.26 (m, 20H); 13C NMR (125 MHz, CD2Cl2) δ 154.9, 
141.1, 129.3, 128.9, 128.5, 127.1, 95.7, 74.8, 59.9, 58.9, 54.9, 35.0, 30.3, 27.5, 27.4, 27.1, 
26.9, 26.4, 26.3, 26.0, 26.0, 21.1; IR (neat) 2925, 2854, 1676, 1455, 1071 cm-1; LRMS 






15-hydroxyicos-19-enoic acid (2.24). Prepared according the general procedure 
described above for the preparation of 2.21 using 16-hydroxyhexadecanoic acid (0.125 g, 
0.460 mmol), DMSO (1.0 mL), IBX (0.14 g, 0.51 mmol), and pentenyl magnesium 
bromide (12 mL of a 0.83 M solution in THF, 10 mmol) to give 110 mg of seco-acid 2.24 
(70%) as a white, waxy solid. mp 63-65 °C; Rf = 0.45 (1:1 EtOAc/hexanes); 500 MHz 
1H NMR (CDCl3) δ 5.80 (dddd, J = 17.0, 10.2, 6.6, 6.6 Hz, 1H), 5.02 (dddd, J = 17.2, 
2.0, 1.6, 1.6 Hz, 1H), 4.96 (dddd, J = 10.2, 2.2, 1.2, 1.2 Hz, 1 H), 3.63-3.59 (m, 2H), 2.35 
(t, J = 7.5 Hz, 2H), 2.12-2.05 (m, 2H), 1.64 (pentuplet, J = 7.4 Hz, 2 H), 1.60-1.26 (m, 27 
H); 13C NMR (CDCl3) δ 178.9, 139.0, 114.8, 72.2, 37.7, 37.1, 34.1, 34.0, 29.9, 29.8, 
29.8, 29.7, 29.6, 29.4, 29.2, 25.8, 25.1, 24.9; IR (neat) 3210 (broad), 2914, 2847, 1695, 
912 cm-1; LRMS Calcd for C21H41O3 m/z (M+H)+ 340.3, found: 341.4  
 
17-(pent-4-enyl)oxacycloheptadecan-2-one, 2.25. Prepared according to the general 
procedure as described for the preparation of 2.18 using 16-hydroxyhenicos-20-enoic 
acid (0.037 g, 0.11 mmol), THF (3.8 mL), Et3N (0.14 mL 0.28 mmol), 2,4,5-
trichlorobenzoyl chloride (0.022 mL, 1.4 mmol), a 3:1 mixture of toluene and THF (50 









macrolactone 2.25 (92%) as a clear colorless oil. Rf 0.25 (50:1 hexanes/EtOAc); 1H NMR 
(500 MHz, CDCl3) δ 5.84-5.74 (m, 1H), 5.00 (partially obscured d, J = 17.1 Hz, 1 H), 
4.98-4.92 (m, 2H), 2.38-2.26 (m, 2H), 2.06 (q, J = 6.7 Hz, 2H), 1.76-1.67 (m, 1 H), 1.62-
1.27 (m, 29 H); 13C NMR (125 MHz, CDCl3) δ 174.0, 138.7, 114.9, 74.2, 34.9, 34.6, 
34.3, 33.8, 29.9, 28.6, 28.5, 28.4, 28.0, 27.8, 27.2, 27.1, 26.9, 25.2, 24.9, 24.9; IR (neat) 
2927, 2856, 1733, 1459, 1260, 1099 cm-1; LRMS calcd m/z for C21H39O2  (MH)+ 323.3, 
found: 323.4 
 
21-oxabicyclo[14.4.1]henicos-1(20)-ene, 2.33. Prepared according to the general 
procedure as described above for the preparation of 2.19 using TiCl4 (0.091 mL, 0.83 
mmol) in CH2Cl2 (8.8 mL), THF (1.04 mL, 11.9 mmol), TMEDA (1.8 mL, 12 mmol) 
activated Zn dust (0.290 g, 4.46 mmol), PbCl2 (0.065 g, 0.24 mmol), and a solution of 
macrolactone 2.25 (0.020 g, 0.062 mmol) and CH3CHBr2 (0.177 mL, 1.98 mmol) in 
CH2Cl2 (0.85 mL + 0.85 mL rinse) to give 20 mg of cyclic enol ether 2.33 (87 %) as a 
clear yellow oil Rf 0.71 (50:1 hexanes/EtOAc). Because of its instability, enol ether 2.33 
was characterized as the corresponding ketobenzoate  as described below. 
To a solution of enol ether 2.33 (0.095 mmol) in CH2Cl2 (9.5 mL) at rt was added 
silica gel (ca. 0.500 g). The resulting slurry was stirred for 8 h and then filtered using 
EtOAc (50 mL). The filtrate was concentrated and the resulting yellow residue that 
contained 6-hydroxycycloicosanone was immediately converted into the corresponding 






To a solution of hydroxy ketone (0.095 mmol) in CH2Cl2 (4.75 mL) at rt was added 
Et3N (0.040 mL, 0.28 mmol) and benzoyl chloride (0.028 mL, 0.24 mmol). The reaction 
mixture was allowed to stir for 4 h and was then diluted with Et2O (50 mL) and the 
reaction was quenched with sat. NaHCO3 (aq., 15 mL).  The organic phase was washed 
with sat. NaHCO3 (aq., 4 x 15 mL), H2O (25 mL), brine (25 mL), dried (MgSO4), and 
concentrated. Preparative TLC (10:1 hexanes/EtOAc) gave 17 mg of benzoate (42% from 
2.25) as a colorless oil. Rf 0.43 (10:1 hexanes/EtOAc); 1H NMR (500 MHz, CDCl3) δ 
8.02 (d, J = 7.3 Hz, 2 H), 7.56 (t, J = 7.1 Hz, 1 H), 7.44 (t, J = 8.0 Hz, 2 H), 5.08 (ddd, J 
= 12.2, 6.1, 6.1, 6.1 Hz, 1H), 2.41 (partially obscured t, J = 7.1 Hz, 2 H), 2.38 (partially 
obscured t, J = 7.1 Hz, 2 H), 1.70-1.57 (m, 8H), 1.31 (m, 24H); 13C NMR (125 MHz, 
CDCl3) δ 211.7, 166.5, 133.2, 131.6, 130.6, 129.9, 128.8, 74.9, 42.9, 42.6, 33.5, 33.1, 
28.8, 28.7, 28.6, 28.5, 28.4, 28.4, 28.3, 28.3, 28.2, 24.9, 24.7 24.3, 24.1; IR (neat) 2927, 
2855, 1714, 1451, 1274, 1113 cm-1; LRMS m/z calcd for C27H43O3 (MH)+ 415.3, found 
415.4. 
 
5-oxocyclononadecyl benzoate (2.34). To a solution of enol ether 2.31 (0.087 mmol) in 
CH2Cl2 (8.7 mL) at rt was added silica gel (ca. 0.500 g). The resulting slurry was stirred 
for 5 h and then filtered using EtOAc (50 mL). The filtrate was concentrated and the 
resulting yellow residue that contained 5-hydroxycyclononadecanone was immediately 
converted into the corresponding benzoyl ester as described below.  





CH2Cl2 (4.4 mL) at rt was sequentially added Et3N (0.20 mL, 0.26 mmol) and benzoyl 
chloride (0.18 mL, 0.22 mmol). After stirring for 4 h the reaction mixture was diluted 
with ether (50 mL) and the reaction was quenched with sat. NaHCO3 (aq., 15 mL). The 
organic phase was washed with sat. NaHCO3 (aq., 4 x 15 mL), H2O (25 mL), brine (25 
mL), dried (MgSO4), and concentrated. Preparative TLC (10:1 hexanes/EtOAc) gave 3.0 
mg of benzoyl ketone 2.34 (63% from 2.23) as a colorless, viscous oil. Rf 0.30 (10:1 
hexanes/EtOAc); 1H NMR (500 MHz, CDCl3) δ 8.06-8.04 (m, 2H), 7.58-7.55 (m, 1H), 
7.46-7.43 (m, 2H), 5.12 (ddd, J = 11.8, 6.0, 6.0 Hz, 1H), 2.52 (ddd, J = 16.1, 6.8, 6.8 Hz, 
1 H), 2.48-2.36 (m, 3H), 1.80-1.58 (m, 8H), 1.40-1.32 (m, 22H); 13C NMR (125 MHz, 
CDCl3) δ 166.5, 133.0, 130.9, 129.8, 128.5, 74.2, 42.7, 42.3, 33.4, 32.9, 28.6, 28.4, 28.2, 
28.1, 28.1, 28.0, 27.9, 27.9, 27.7, 24.1, 23.9, 19.8; IR (neat) 2927, 2855, 1714, 1453, 
1274, 1113 cm-1; LRMS m/z calcd for C26H41O3  (MH)+ 401.2, found: 401.1 
 
16-methoxy-20-oxabicyclo[14.3.1]icosan-17-ol, 2.35. To a solution of enol ether 2.31 
(0.043 mmol) in MeOH (1.00 mL) at 0 °C was added meta-chloroperoxybenzoic acid 
(77%) (11.0 mg, 0.047 mmol). After stirring at 0 °C for 3 h, the reaction was quenched 
with sat. Na2S2O3 (aq., 10 mL), and the resulting mixture diluted with ether (20 mL). The 
organic phase was washed with NaHCO3 (aq., 2 x 10 mL) and sat. NaCl (aq., 10 mL). 
The organic layer was dried (Na2SO4) and concentrated. Flash chromatography 
(hexanes:ethyl acetate, 20:1) gave 9.5 mg of hydroxy ketal 2.35 (68%) as a 3:1 mixture of 






MHz, CDCl3) δ 3.63-3.59 (m, 1H), 3.52-3.50 (m, 1H), 3.27 (s, 3H, major diastereomer), 
3.23 (s, 3H, minor diastereomer), 2.07 (dddd, J = 13.7, 13.7, 4.9, 2.4 Hz, 1H), 1.81-1.26 
(m, 31H); 13C NMR (125 MHz, CDCl3) δ 100.3, 69.8, 69.1, 47.4, 35.2, 32.1, 30.7, 28.6, 
28.4, 28.1, 28.1, 27.8, 27.7, 27.6, 27.4, 27.3, 27.2, 24.1, 22.8; LRMS Calcd for C19H37O 
m/z (MNa)+ 349.2, found 349.2. 
 
20-oxabicyclo[14.3.1]icosane, 2.36. To a solution of enol ether 2.31 (0.025 g, 0.089 
mmol) and triethylsilane (0.043 mL, 0.267 mmol) in CH2Cl2 ( 1.00 mL) at 0 °C was 
added trifluoroacetic acid (0.013 mL, 0.18 mmol). After 10 min, the reaction was 
quenched with sat. NaHCO3 (aq., 10 mL), and the resulting mixture diluted with ether (20 
mL). The organic phase was washed with H2O (10 mL) and sat. NaCl (aq., 10 mL). The 
organic layer was dried (Na2SO4) and concentrated. Flash chromatography (hexanes to 
hexanes:ethylacetate, 100:1)gave 21 mg of tetrahydropyran 2.36 (87%)asaclearcolorless 
oil: Rf 0.42 (50:1 hexanes/EtOAc); 1H NMR (500 MHz, CDCl3) δ 3.2 (t, J = 9.8 Hz, 2H), 
1.79-1.16 (m, 34 H); 13C NMR (125 MHz, CDCl3) δ 36.9, 32.6, 28.9, 28.5, 27.7, 27.6, 
27.5, 25.6, 24.3; IR (neat) 2927, 2855, 1457, 1085 cm-1; LRMS Calcd for C19H37O m/z 
(MH)+ 281.2, found 281.1. 
 









a solution of (S)-phosphonate 2.43 (0.609 g, 1.79 mmol) in THF (4.5 mL) at 0 °C was 
added sodium hexamethyldisilazide (1.50 mL of a 1.0 M solution in THF, 1.50 mmol). 
After 5 min, the cooling bath was removed and the reaction mixture was warmed to rt. 
After 1 h the solution was cooled to 0 °C and a solution of aldehyde 2.42 (0.377 g, 1.19 
mmol) in THF (3.30 mL) was added. After 2 h, the reaction was quenched with pH 7 
phosphate buffer (10 mL) and the resulting mixture diluted with EtOAc (50 mL). The 
organic phase was washed with 1M KHSO4 (aq., 20 mL), H2O (20 mL), sat. NaHCO3 
(aq., 20 mL), and sat. NaCl (aq., 20 mL). The organic layer was dried (Na2SO4) and 
concentrated. Flash chromatography (hexanes:ethyl acetate, 10:1 to 5:1) gave 417 mg of 
unsaturated imide 2.44 (70%) as a clear colorless oil: Rf 0.62 (5:3 hexanes/EtOAc); 1H 
NMR (500 MHz, CDCl3) δ 7.30-7.16 (m, 10H), 7.04-6.98 (m, 1H), 5.74 (dddd, J = 17.1, 
10.25, 6.8, 6.8 Hz, 1H), 5.38 (dd, J = 8.79, 3.9 Hz, 1H), 4.93 (ddd, J = 17.1, 2.0, 2.0 Hz, 
1H), 4.80 (dd, J = 10.3, 1.0 Hz, 1H), 4.58 (t, J = 8.8 Hz, 1H), 4.41 (dd, J =  16.1, 11.2 
Hz, 2H), 4.17 (ddd, J = 8.8, 1.5, 3.9, Hz, 1H), 3.31 (dddd, J = 11.7, 5.9, 5.9, 5.9 Hz, 1H), 
2.17 (ddd, J = 7.3, 7.3, 7.3 Hz, 2H), 2.12-2.01 (m, 2H), 1.61-1.19 (m, 19H); 13C NMR 
(125 MHz, CDCl3) δ 164.8, 153.8, 152.4, 139.3, 139.2, 138.9, 129.3, 129.3, 128.7, 128.5, 
128.4, 128.4, 128.4, 128.4, 127.9, 127.5, 127.5, 126.1, 120.3, 114.6, 78.5, 77.5, 77.2, 
77.0, 57.9 (2), 33.9 (2), 33.3 (2), 32.9 (2), 29.9 (2), 29.8 (3), 29.6 (3), 29.5 (2), 29.3 (3), 
28.2 (3), 25.4; DEPT (125 MHz, CDCl3) δ CH2: 114.6, 70.9, 70.1, 33.9, 33.3, 32.9, 29.9, 
29.8, 29.6, 29.5, 29.3, 28.2, 25.4. CH: 152.4, 138.9, 129.3, 128.7, 128.4, 127.9, 127.5, 
126.1, 120.3, 78.5, 57.9; IR (neat) 2929, 2855, 1781, 1689, 1636, 1455, 1383, 1350, 




(2.45). To a slurry consisting of CuBr•SMe2 (0.421 g, 2.05 mmol) and THF (3.5 mL) was 
added Me2S (2.35 mL) and cooled to -78 °C. To this was slowly added MeMgBr (0.95 
mL of a 3.0 M solution in Et2O, 1.10 mmol). After 20 min, the mixture was warmed to 0° 
C and kept at that temperature for 0.5 h. The reaction mixture was cooled to -78 °C and 
transferred to a solution of enimide 2.44 (413 mg, 0.821 mmol) in THF (2.0 mL) and 
CH2Cl2 (1.0 mL) at -78 °C. After 0.5 h, the reaction mixture was warmed to -40 °C and 
allowed to stir for 2.5 h after which the reaction was quenched with pH 7 phosphate 
buffer (20 mL) and diluted with 1:1 EtOAc:hexanes (50 mL). The organic phase was 
washed with 1 M KHSO4 (aq., 2 x 25 mL), H2O (25 mL), and sat. NaCl (aq., 25 mL). The 
organic phase was dried (Na2SO4) and concentrated. Flash chromatography 
(hexanes:ethyl acetate, 50:1 to 20:1 to 10:1) gave 282 mg of enimide 2.44 (69%) as a 
clear colorless oil: Rf 0.74 (5:3 hexanes/EtOAc).  1H NMR (500 MHz, CDCl3) δ 7.40-
7.27 (m, 10 H), 5.84 (dddd, J = 16.6, 9.8, 6.4, 6.4 Hz, 1H), 5.44 (dd, J = 8.8, 3.9 Hz, 
1H), 5.03 (ddd, J = 16.4, 1.5, 1.5 Hz, 1H), 4.97-4.95 (m, 1H), 4.68 (dd, J = 9.3, 9.3 Hz, 
1H), 4.26 (dd, J = 8.8, 3.4 Hz, 1 H), 3.41 (ddd, J = 5.8, 5.8, 5.8 Hz, 1 H), 2.85 (d, J = 6.8 
Hz, 2 H), 2.23-2.09 (m, 2 H), 2.03-1.95 (m, 1 H), 1.70-1.47 (m, 4 H), 1.40-1.20 (m, 13 
H), 0.80 (d, J = 6.83 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 172.5, 153.9, 139.4, 139.3, 
139.0, 129.3, 128.8, 128.5, 127.9, 127.6, 126.1, 114.6, 78.6, 77.5, 77.2, 77.0, 71.0, 70.0, 
57.8, 42.8, 36.8, 34.0, 33.3, 30.0, 29.9, 29.9, 29.8, 29.8, 27.1, 25.5, 19.9; DEPT (125 








29.8, 27.2, 25.5, 19.9. CH: 139.0, 129.3, 128.8, 128.5, 128.0, 127.6, 126.1, 78.6, 57.8, 
29.9. IR (neat) 2928, 2855, 1783, 1706, 1384, 1324, 1200, 1064 cm-1; LRMS m/z calcd 
for C33H45NO4Na  (M+Na)+ 542.3, found 542.4. 
 
(S)-3-((R)-11-hydroxy-3-methylpentadec-14-enoyl)-4-phenyloxazolidin-2-one, (S1). 
To a mixture of imide 2.45 (0.282 g, 0.558 mmol), CH2Cl2 (9.0 mL), and H2O (1.0 mL) at 
0 ºC was added DDQ (0.252 g, 1.11 mmol). After 4 h the reaction was quenched with sat. 
NaHCO3 (aq., 30 mL) and diluted with CH2Cl2 (40 mL). The organic phase was washed 
with sat. NaHCO3 (aq., 30 mL) and sat. NaCl (aq., 20 mL), dried (Na2SO4), and 
concentrated. Flash chromatography (hexanes:EtOAc, 10:1 to 5:1) gave 0.213 g of imide 
S1 (92%) as a clear colorless oil: Rf 0.60 (5:3 hexanes/EtOAc); 1H NMR (500 MHz, 
CDCl3) δ 7.36-7.23 (m, 5H), 5.82 (dddd, J = 17.1, 13.4, 6.8, 3.4 Hz, 1H), 5.41 (ddd, J = 
8.7, 3.6, 3.6 Hz, 1H), 5.02 (dddd, J = 17.1, 3.4, 3.4, 2.0 Hz, 1H), 4.94 (dddd, J = 10.2, 
3.4, 3.4, 1.5 Hz, 1H), 4.64 (ddd, J = 8.8, 8.8, 3.4 Hz, 1H), 4.23 (ddd, J = 8.7, 4.0, 4.0 Hz, 
2H), 3.61-3.55 (broad m, 1H), 2.80 (dd, J = 6.8, 3.4 Hz, 2H), 2.22-2.06 (m, 2H), 1.98-
1.92 (m, 2H), 1.70 (brs, 1H), 1.58-1.18 (m, 16H), 0.84 (d, J = 6.4, 3H); 13C NMR (125 
MHz, CDCl3) δ 172.6, 153.9, 139.4, 138.9, 129.3, 128.8, 126.1, 114.9, 71.7, 70.0, 57.8, 
42.8, 37.7, 36.7, 36.7, 30.3, 29.9, 29.9, 29.8, 29.7, 29.7, 29.7, 27.1, 25.8, 19.9; IR (neat) 
3500, 2927, 2854, 2784, 1705, 1385, 1325, 1200 cm-1; LRMS m/z calcd for C26H40NO4 









(R)-11-hydroxy-3-methylpentadec-14-enoic acid, (2.46). To a mixture of imide S1 
(0.213 g, 0.513 mmol), THF (4 mL), and H2O (1.1 mL) at 0 ºC was added H2O2 (0.20 mL 
of a 50% aq. solution) dropwise followed by LiOH (0.025 g, 1.0 mmol). The reaction 
mixture was kept at 0 °C for 5 min and then warmed to rt and kept at that temperature for 
2 h. The reaction was quenched with sat. Na2SO3 (aq., 5 mL), stirred for 10 min, and then 
concentrated to remove THF.  The resulting aqueous residue was acidified to pH 3 
(glacial acetic acid) and exacted with EtOAc (3 x 100 mL). The organic extracts were 
combined, dried (Na2SO4), and concentrated. Flash chromatography (hexanes:EtOAc, 
5:3) gave 113 mg of seco-acid 2.46 (77%) as a clear colorless oil: Rf 0.20 (5:3 
hexanes/EtOAc); [α]D20 +2.66 (c = 1.135, CHCl3); 1H NMR (500 MHz, CDCl3) δ 5.85 
(dddd, J = 17.1, 10.3, 6.8, 6.8 Hz, 1H), 5.06 (ddd, J = 17.1, 3.4, 1.4 Hz, 1H), 4.99-4.96 
(m, 1H), 3.66-3.62 (m, 1H), 2.34 (ddd, J = 15.1, 6.3, 1.9 Hz, 1H), 2.25-2.10 (m, 3H), 
1.99-1.92 (m, 1H), 1.61-1.21 (m, 18H), 0.97 (d, J = 6.8 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) δ 138.8, 114.9, 71.9, 71.8, 37.6, 36.8, 36.7, 36.6, 36.6, 30.4, 30.3, 29.8, 29.7, 
29.7, 29.6, 29.6, 29.5, 27.0, 25.7, 19.9; DEPT (125 MHz, CDCl3) δ CH3 19.9; CH2 114.9, 
37.6, 36.8, 36.7, 36.6 (2), 30.2, 29.8, 29.7, 29.6, 29.6, 29.6, 29.5, 27.0, 25.7; CH: 138.8, 
71.8 (2), 30.4. IR (neat) 3500-2700 (broad), 2928, 2855, 1710, 1489, 1294 cm-1; LRMS 







(R)-7-methylcyclopentadecane-1,5-dione. To a solution of seco-acid 2.46 (20. mg, 
0.074 mmol) in THF (4.8 mL) at rt was added Et3N (0.053 mL, 0.37 mmol) and 2,4,5-
trichlorobenzoyl chloride (0.030 mL, 0.19 mmol). After 5 h the reaction mixture was 
diluted with a 3:1 mixture of toluene and THF (50 mL) and then transferred over 14 h 
into a solution of DMAP (351 mg, 2.88 mmol) in toluene (120 mL) at 48 ºC. The reaction 
mixture was stirred for an additional 2 h and then concentrated. The resulting residue was 
passed through a plug of silica gel and then concentrated to give 16 mg of macrolactone 
2.47 (81%) as a clear colorless oil: Rf 0.40 (10:1 hexanes/EtOAc). Macrolactone 2.47 
was taken on directly to the olefinic-lactone cyclization reaction to give 2.48 as described 
below.  
Macrocyclic enol ether 2.48 was prepared according to the general procedure as 
described for the preparation of 2.19 using TiCl4 (0.21 mL, 1.9 mmol) in CH2Cl2 (8.6 
mL), THF (1.0 mL, 12 mmol), TMEDA (1.7 mL, 12 mmol), activated Zn dust (0.28 g, 
4.3 mmol), PbCl2 (0.063 g, 0.23 mmol), and a solution of macrolactone 2.47 (0.016 g, 
0.060 mmol) and CH3CHBr2 (0.17 mL, 1.9 mmol) in CH2Cl2 (1.0 mL + 1.0 mL rinse) to 
give 12.1 mg of cyclic enol ether 2.48 (69 %) as a clear yellow oil. 2.48 was taken 
directly to the hydrolysis step to give 2.49 as described below. 
To a solution of enol ether 2.48 in CH2Cl2 (8.7 mL) at rt was added silica gel (ca. 0.5 




concentrated and filtered using EtOAc (50 mL). The filtrate was concentrated to afford 
12.6 mg of 2.49 (98%) as a yellow residue that was immediately taken to the subsequent 
diketone or thiocarbonate formation.  
To a solution of hydroxy ketone 2.49 (0.050 mmol) from above in CH2Cl2 (1.00 mL) 
at 0 °C was added the Dess-Martin periodinane (0.042 g, 0.10 mmol). The reaction was 
allowed to stir for 1 h and then loaded directly onto a silica gel column (hexanes:ethyl 
acetate, 50:1 to 20:1 to 10:1) to give 11.2 mg of diketone 2.50 (89% from 2.46) as a 
crystalline solid. Rf 0.22 (10:1 hexanes/EtOAc); [α]D20 -5.33 (c = 0.15, CHCl3); 1H NMR 
(500 MHz, CDCl3) δ 2.67-2.27 (m, 7H), 2.15 (dd, J = 15.4, 4.0 Hz, 1H), 2.11-2.03 (m, 
1H), 1.89-1.82 (m, 2H), 1.78-1.68 (m, 1H), 1.62-1.52 (m, 1H), 1.34-1.08 (m, 12H), 0.93 
(d, J = 6.7 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 212.1, 211.4, 50.3, 41.8, 41.5, 41.4, 
36.5, 29.1, 28.1, 27.5, 27.4, 26.9, 25.4, 23.5, 21.9, 17.6; IR (neat) 2927, 2853, 1706, 
1400, 1065 cm-1; LRMS m/z calcd for C16H28O2Na  (M+Na)+ 275.2, found 275.2.  
 
(R)-(+)-Muscopyridine. A solution of diketone 2.50 (0.016 g, 0.063 mmol), EtOH (3.2 
mL) and hydroxylamine hydrochloride (0.11 g, 1.6 mmol) was heated at 160 °C for 18.5 
h in a sealed tube. After the reaction mixture was cooled to rt, it was diluted with ether (7 
mL) and the reaction was quenched with NaHCO3 (ca. 0.15 g). The resulting mixture was 
filtered through SiO2 using EtOAc. Concentration and flash chromatography (50:1 to 
20:1 hexanes:ethyl acetate) gave 5.7 mg of muscopyridine (41%) as a colorless oil: Rf  
N
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0.78 (5:1 hexanes/EtOAc); [α]D20 +7.3 (c = 0.58, CHCl3); 1H NMR (500 MHz, CDCl3) d 
7.48 (t, J = 7.5 Hz, 1H), 6.95 (t, J = 6.6 Hz, 2H), 2.94 (dd, J = 13.2, 3.7 Hz, 1H), 2.91-
2.78 (partially obscured m, 1H), 2.52 (dd, J = 12.8, 10.0 Hz, 1 H), 2.10-2.00 (m, 1H), 
1.82 (pentuplet, J = 6.1 Hz, 2H), 1.27-1.15 (m, 13H), 1.07 (d, J = 6.8 Hz, 3 H); 13C NMR 
(125 MHz, CDCl3) δ 162.1, 161.3, 136.7, 121.1, 120.8, 45.8, 37.4, 34.6, 34.1, 30.2, 28.3, 
26.9, 26.7, 26.5, 25.6, 23.5, 22.6; IR (neat) 2926, 2854, 1576, 1458 cm-1; LRMS m/z 
calcd for C16H26N (MH)+ 232.2, found 232.3.  
 
O-(7R)-7-methyl-5-oxocyclopentadecyl O-phenyl carbonothioate S2. To a solution of  
hydroxy ketone 2.49 (0.058 mmol) in CH2Cl2 (0.75 mL) at 0 °C was added pyridine (0.10 
mL, 0.90 mmol), DMAP (ca. 0.010 g) and phenyl chlorothionoformate (0.040 mL, 0.29 
mmol). The reaction was allowed to slowly warm to rt over 10 h before being quenched 
with sat. NH4Cl (aq., 10 mL) and diluted with a 1:1 mixture of EtOAc/hexanes (50 mL). 
The organic phase was washed with H2O (10 mL), and sat. NaCl (aq., 10 mL), dried 
(Na2SO4), and concentrated. Flash chromatography (hexanes:ethyl acetate, 50:1 to 20:1 to 
10:1) gave 7.5 mg of thiocarbonate S2 (33%) as a clear colorless oil: Rf 0.74 (5:3 
hexanes/EtOAc); 1H NMR (500 MHz, CDCl3) δ 7.43 (dt, J = 7.5, 1.3 Hz, 2H), 7.31 
(partially obscured dt, J = 7.0, 1.1 Hz, 1H), 7.11 (d, J = 7.5 Hz, 2H), 5.34 (dddd, J = 5.5, 






1H), 2.12-2.03 (m, 1H), 1.90-1.80 (m, 4H), 1.74-1.64 (m, 2H), 1.44-1.20 (m, 14H), 0.96 
(d, J = 6.8, 1.5 H), 0.95 (d, J = 6.8 Hz, 1.5 H); 13C NMR (125 MHz, CDCl3) δ 211.4, 
195.0, 153.6, 129.7, 126.7, 122.2, 84.5, 50.7, 42.1, 36.2, 31.7, 31.7, 29.3, 27.4, 26.9, 26.7, 
26.5, 25.6, 23.5, 21.6, 19.3; IR (neat) 2927, 2857, 1710, 1490. 1457. 1276, 1200 cm-1; 
LRMS m/z calcd for C23H34O3SNa (M+Na)+ 413.2, found 413.2. 
  
(R)-(-)-Muscone. To a solution of thiocarbonate S2 (0.075 g, 0.019 mmol) and Bu3SnH 
(0.022 mL, 0.022 mmol) in toluene (3.5 mL) was added a spatula tip of AIBN. The 
reaction mixture was then heated at reflux for 4 h, cooled to rt, and loaded directly onto a 
silica gel column (hexanes:ethyl acetate, 50:1 to 20:1) to give 4.5 mg of muscone (97%) 
as a colorless oil. Rf 0.74 (5:3 hexanes/EtOAc); [α]D20 -7.3 (c = 0.54, MeOH); 1H NMR 
(500 MHz, CDCl3) δ 2.46-2.40 (m, 3H), 2.18 (dd, J = 15.2, 5.1 Hz, 1H), 2.12-2.02 (m, 
1H), 1.73-1.55 (m, 2H), 1.40-1.20 (brs, 20H), 0.93 (d, J = 6.6 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 212.3, 50.6, 49.3, 35.8, 29.9, 29.3, 27.8, 27.3, 26.9, 26.8, 26.8, 26.7, 
26.5, 26.4, 25.2, 23.3, 21.3; IR (neat) 2924, 2853, 1710, 1460, 1109 cm-1; LRMS Calcd 
for C16H31O m/z (MH)+ 239.2, found 239.2.  
	  	  








To a solution of the D-glucopyranoside 2.64 (350 mg, 0.687 mmol, 1.00 eq) in CH2Cl2 
(3.40 mL, 0.2 M) at 0 °C was added dimethyldioxirane (17.2 mL of a 0.1 M solution, 
1.72 mmol, 2.50 eq). After stirring for 10 minutes, the reaction was concentrated under 
high vacuum to afford the corresponding epoxide. The resulting clear oil was taken up in 
THF (5.73 mL, 0.12 M) and cooled to 0 °C. To this solution was added propargyl 
magnesium bromide (1.43 mL of a 1.20 M solution in ether, 1.72 mmol, 2.50 eq); 
prepared from the addition of neat propargyl bromide (1.52 mL, 0.15 mmol, 1.00 eq) to a 
slurry of magnesium turnings (365 mg, 0.15 mmol, 1.00 eq) and a catalytic amount of 
HgCl2 (ca. 0.001 g) in ether (11.50 ml, 1.20 M). After stirring for 20 minutes at 0 °C, the 
reaction was allowed to warm to RT over 1 h and then quenched with sat. aq. NH4Cl. 
After stirring for 10 min, the mixture the aqueous phase was separated and was extracted 
with CH2Cl2 (3 x 50 mL). The organic extracts were dried over Na2SO4, filtered and 
concentrated under reduced pressure. Flash chromatography  (Hexanes-EtOAc 50:1, then 
20:1) afforded alcohol 2.66 (287 mg, 72%) as a colorless oil. 1H NMR (500 MHz, C6D6): 
d 7.95-7.93 (m, 2H), 7.82-7.80 (m, 2H), 7.28-7.21 (m, 6H), 4.13-4.10 (dd, J = 9.7, 4.8 
Hz, 1H), 3.98 (t, J = 9.28, 9.28 Hz, 1H), 3.96 (t, J = 10.26, 10.26 Hz, 1H), 3.73 (t, J = 
8.79, 8.79 Hz, 1H), 3.15 (ddd, J = 10.26, 10.26, 5.24 Hz, 1H), 2.89 (ddd, J = 9.28, 5.86, 
3.42 Hz, 1H), 2.46-2.28 (m, 2H), 1.74 (t, J = 2.4, 2.4 Hz, 1H), 1.21 (s, 9H), 1.09 (s, 9H), 
1.04 (s,9H); 3C (125MHz, C6D6): 
137.2, 136.1, 135.7, 133.1, 130.6, 130.4, 81.4, 80.9, 78.6, 77.6, 75.4, 74.7, 70.7,67.1, 28.1
27.6, 23.2, 22.4, 20.5. IR(CH2Cl2) 2891, 2859, 1744, 1483, 1225, 1106 cm-1. LRMS 





d][1,3,2]dioxasilin-7-yl acetate, 2.67 To a solution of alcohol 2.66 (100 mg, 0.172 
mmol) and CH2Cl2 (0.81 mL, 0.20 M) at RT was sequentially added (i-Pr)2NEt (0.238 
mL, 1.37 mmol, 8.0 eq), acetic anhydride (0.097 mL, 1.03 mmol, 6.0 eq) and DMAP (ca. 
0.005 g). After stirring overnight, the reaction was quenched with sat. aq. NH4Cl (50 
mL). The layere were separated and the aqueous phase was extracted with CH2Cl2 (3 x 50 
mL), dried over Na2SO4 and concentrated. Flash chromatography (Hexanes-EtOAc 50:1, 
then 20:1) gave acetate 2.67 (98.2 mg, 98%) as a clear viscous oil. 1H NMR (500 MHz, 
C6D6): d  8.08-8.00 (m, 2H), 7.74-7.70 (m, 2H), 7.35-7.26 (m, 6H), 4.98 (t, J = 9.28, 9.28 
Hz, 1H), 4.08 (dd, J = 10.25, 4.88 Hz), 3.90-3.77 (m, 4H), 3.10 (ddd, J = 9.77, 9.77, 4.89 
Hz, 1H), 2.90 (ddd, J = 11.72, 6.35, 4.88 Hz, 1H), 2.36-2.33 (m, 2H), 1.66 (t, J = 2.44, 
2.44, 1H), 1.19 (s, 9H), 1.10 (s, 9H), 1.08 (s, 3H), 1.06 (s, 9H). 13C (125 MHz, C6D6) d 
170.73, 137.38, 136.46, 135. 46, 132.54, 130.69, 129.94, 80.87, 78.82, 78.04, 77.60, 75.5, 
70.37, 66.87, 28.21, 27.66, 27.61, 23.65, 23.22, 20.68, 20.52, 20.46. LRMS calc’d for 
C30H32O5 (MH+) 623.3, found 623.3.                                                
	  
3-(3,4,6-Tri-O-benzyl-b-D-glucopyranosyl)-1-propyne, 2.69. To a solution of tri-O-












was added dimethyldioxirane (9.0 mL of a 0.1 M solution, 0.90 mmol, 2.50 eq). After 
stirring for 10 minutes, the reaction was concentrated under high vacuum to afford the 
corresponding epoxide. The resulting white solid was taken up in THF (3.0 mL, 0.12 M) 
and cooled to 0 °C. To this solution was added propargyl magnesium bromide (0.75 mL 
of a 1.20 M solution in ether, 0.90 mmol, 2.50 eq); prepared similarly as shown in the 
experimental details for substrate 2.66 After stirring for 20 minutes at 0 °C, the reaction 
was allowed to warm to RT over 1 h and then quenched with sat. aq. NH4Cl (10 mL). 
After stirring for 10 min, the layers were separated. The aqueous phase was extracted 
with CH2Cl2 (3 x 50 mL). The organic phases were dried over Na2SO4, filtered and 
concentrated under reduced pressure. Flash chromatography  (Hexanes-EtOAc 20:1, 
10:1, then 5:1) afforded alcohol 2.69 (132 mg, 78%) as a colorless oil. 1H NMR (500 
MHz, CDCl3): d 7.42-7.24 (m, 13H), 7.22-7.21 (m, 2H), 4.98 (d, J = 11.5 Hz, 1H), 4.83 
(d, J = 11.1 Hz, 1H), 4.78 (d, J = 11.7 Hz, 1H), 4.70 (d, J = 12.2 Hz, 1H), 4.62 (d, J = 
10.8 Hz, 1H), 4.61 (d, J = 12.1 Hz, 1H), 3.78-3.49 (m, 6H), 3.48-3.43 (m, 1H), 2.72 
(dddd, J = 16.7, 3.2, 3.2, 1.0 Hz, 1H), 2.58 (ddd, J = 17.2, 5.8, 2.7 Hz, 1H), 2.38 (s, 1H), 
2.04 (dd, J = 2.6, 2.6 Hz, 1H); 13C (125MHz, CDCl3): 
δ 138.7, 138.4, 138.2, 128.8, 128.6, 128.5, 128.5, 128.1, 128.0, 128.0, 127.7, 86.6, 80.7, 7
9.5, 78.4, 77.8, 77.3, 77.1, 75.4, 75.0, 73.6, 73.1, 70.4, 68.9, 22.2; IR (CCl4) 3571, 3310, 
2864, 1448, 1100 cm-1. LRMS calc’d for C30H32O5 (MH+) 473.2, found 473.2.  
 
4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(propynyl)tetrahydro-2H-pyran-3-yl-







0.20 M) at RT was sequentially added (i-Pr)2NEt (0.296 mL, 1.70 mmol, 8.00 eq), added 
acetic anhydride (0.120 mL, 1.27 mmol, 6.00 eq) and a catalytic amount of DMAP (ca. 
0.005 g). After stirring overnight, the reaction was quenched with sat. aq. NH4Cl (50 
mL). The layers were sperated and the aqueous phase was extracted with CH2Cl2 (3 x 50 
mL). The combined organic phases were dried over Na2SO4 and concentrated. Flash 
chromatography (Hexanes-EtOAc 50:1, then 20:1) gave acetate 2.70 (104 mg, 96%) as a 
clear viscous oil. 1H NMR (500 MHz, CDCl3): d 7.33–7.15 (m, 15H), 4.99 (t, J = 9.30, 
9.30 Hz), 4.85–4.52 (m, 6H), 3.80–3.62 (m, 4H), 3.53–3.42 (m, 2H), 2.49–2.45 (m, 2H), 
1.99 (t, J = 2.4 Hz, 1H), 1.95 (s, 3H). 13C (125 MHz, CDCl3): 
d 138.7, 138.4, 138.2, 128.8, 128.6, 128.5, 128.5, 128.1, 128.0, 128.0, 127.7, 86.6, 80.7, 7
9.5, 78.4, 77.8, 77.3, 77.1, 75.4, 75.0, 73.6, 73.1, 70.4, 68.9, 22.2 LRMS calc’d for 
C32H34O6 (MH+) 515.2, found 515.2.  
 
1-(tert-butyldiphenylsilyloxy)oct-7-yn-4-yl-acetate, 2.73. Known aldehyde 2.7127 (333 
mg, 1.065 mmol, 1.00 eq) was taken up in THF (5.5 mL, 0.20 M) and cooled to 0°C. The 
TMS homopropargyl Grignard28 (9.00 mL of a 0.26 M solution, 2.34 mmol 2.20 eq.) was 
added over 1 h via syringe pump. After the addition, the reaction was allowed to warm to 
RT and stirred overnight. The reaction was then cooled to 0°C and quenched with sat. aq. 
NH4Cl (50 mL). The phases were separated and the aqueous layer was extracted with 
diethyl ether (3 X 50 mL). The combined organic extracts were washed with dried over 
Na2SO4 and concentrated. 




anhyd. K2CO3 (gross excess) in one portion, at RT. The reaction was allowed to stir for 
an hour before it was diluted with H2O (15 mL). The reaction mixture was extracted with 
CH2Cl2 (3 X 50 mL) and the combined organic extracts were dried over Na2SO4 and 
concentrated to give a yellow residue. 
The crude terminal alkyne was then subjected to standard acylation conditions. (i-
Pr)2NEt (1.19 mL, 8.52 mmol, 8.00 eq), acetic anhydride (.603 mL, 6.39 mmol, 6.00 eq), 
and DMAP (ca. 0.01 g) were sequentially added to the crude residue at RT. After stirring 
overnight, the reaction was quenched with sat. aq. NH4Cl (35 mL). The separated 
aqueous phase was extracted with CH2Cl2 (3 X 50 mL). The combined organic layers 
were dried over Na2SO4 and concentrated. Flash chromatography (Hexanes-EtOAc 50:1, 
then 20:1) gave the metathesis precursor 2.73 (266 mg, 60% over 3 steps) as a yellow oil. 
1H NMR (500 MHz, C6D6): d 7.78-7.76 (m, 4H), 7.24-7.23 (m, 6H), 5.10-4.98 (m, 1H), 
3.57 (t, J = 4.97, 4.97 Hz, 2H), 2.25-1.99 (m, 2H), 1.74 (t, J = 2.44, 2.44 Hz, 1H), 1.63 (s, 
3H), 1.14 (s, 9H), 1.44-1.42 (m, 2H), 1.23-1.27 (m, 2H). 13C (125 MHz, C6D6): d 186.35, 
136.33, 133.84, 128.94, 83.83, 72.97, 69.50, 64.20, 33.65, 30.90, 28.95, 27.48, 21.02, 
15.43. IR (CH2Cl2) 3071, 2927, 2856, 1738, 1429, 1373, 1240, 1109 cm-1. LRMS calc’d 




2.74. A two-necked flask fitted with a condenser was cooled to 0 °C and charged with 









resulting solution was added THF (1.09 mL, 12.28 mmol, 192.0 eq) dropwise at which 
time the solution turned yellow. The addition of THF was followed by the dropwise 
addition of TMEDA (1.85 mL, 12.28 mmol, 192.0 eq) resulting in the formation of a 
clear brown solution. The ice bath was removed and the mixture was allowed to stir for 
20 min. Activated Zn dust (300 mg, 4.68 mmol, 72.0 eq) and PbCl2 (67.6 mg, 2.43 mmol, 
3.80 eq) were then added. The resulting mixture went through a series of color changes 
from brown to green to purple and finally to blue-green over the course of 3-5 min. To 
the slurry was transferred a solution of ester 2.67 (40.0 mg, 0.064 mmol, 1.0 eq) and 
CH3CHBr2 (0.186 mL, 2.05 mmol, 32.0 eq) in CH2Cl2 (0.90 mL + 0.90 mL rinse, .036 
M) via cannula. The reaction mixture was then either heated to reflux for 1.15 h or 
allowed to stir at rt for 2 h. Following this time period the mixture was cooled to 0 °C and 
quenched with sat K2CO3 (aq., 0.5 mL). After stirring for 30 min at 0 °C, the resulting 
mixture was filtered through a cotton plug. To the filtrate was added neutral SiO2 (ca. 100 
mg) and was concentrated. The SiO2 was collected and loaded onto a plug of SiO2 where 
it was eluted with 100:1 hexanes-ethyl acetate to give a yellow oil. Flash chromatography 
(200:1 hexane-ethyl acetate, then 50:1 hexane-ethyl acetate) gave the 1,3-diene 2.74 
(26.0 mg, 64%) as an odorless and colorless oil. 1H NMR (500 MHz, CD2Cl2): d 7.82 (m, 
2H), 7.70 (m, 2H), 7.42-7.34 (m, 6H), 6.42 (dd, 17.09, 10.74 Hz, 2H), 4.81 (dd, J = 
17.09, 0.97 Hz, 1H), 4.73 (d, J = 10.79), 4.13-4.09 (m, 1H), 4.00 (t, J = 8.79, 8.79 Hz, 
1H), 3.73 (t, J = 10.25, 10.25 Hz, 1H), 3.47 (t, J = 9.76, 9.76 Hz, 1H), 3.40-3.31 (m, 2H), 
2.35 (dd, J = 15.14, 5.37 Hz, 1H), 2.00 (m, 1H), 1.18 (s, 3H), 1.08 (s, 9H), 1.06 (s, 9H), 
0.98 (s, 9H). 13C (125 MHz, CD2Cl2): d 137.02, 136.30, 134.40, 130.07, 129.51, 127.98, 
127.59, 127.53, 107.83, 105.85, 79.38, 78.62, 77.70, 75.48, 73.11, 66.94, 30.25, 28.11, 
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27.90, 27.34, 27.31, 23.17, 20.31, 15.27.  IR (CD2Cl2) 3071, 2933, 2859, 1642, 1472, 
1428, 1387, 1166, 1112, 1051, 827 cm-1. LRMS calc’d for C26H34O3Si (MH+) 621.1, 
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